Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
54 "Pheochromocytoma"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Review Article
Miscellaneous
Toward Systems-Level Metabolic Analysis in Endocrine Disorders and Cancer
Aliya Lakhani, Da Hyun Kang, Yea Eun Kang, Junyoung O. Park
Endocrinol Metab. 2023;38(6):619-630.   Published online November 21, 2023
DOI: https://doi.org/10.3803/EnM.2023.1814
  • 9,085 View
  • 206 Download
  • 4 Web of Science
  • 5 Crossref
AbstractAbstract PDFPubReader   ePub   
Metabolism is a dynamic network of biochemical reactions that support systemic homeostasis amidst changing nutritional, environmental, and physical activity factors. The circulatory system facilitates metabolite exchange among organs, while the endocrine system finely tunes metabolism through hormone release. Endocrine disorders like obesity, diabetes, and Cushing’s syndrome disrupt this balance, contributing to systemic inflammation and global health burdens. They accompany metabolic changes on multiple levels from molecular interactions to individual organs to the whole body. Understanding how metabolic fluxes relate to endocrine disorders illuminates the underlying dysregulation. Cancer is increasingly considered a systemic disorder because it not only affects cells in localized tumors but also the whole body, especially in metastasis. In tumorigenesis, cancer-specific mutations and nutrient availability in the tumor microenvironment reprogram cellular metabolism to meet increased energy and biosynthesis needs. Cancer cachexia results in metabolic changes to other organs like muscle, adipose tissue, and liver. This review explores the interplay between the endocrine system and systems-level metabolism in health and disease. We highlight metabolic fluxes in conditions like obesity, diabetes, Cushing’s syndrome, and cancers. Recent advances in metabolomics, fluxomics, and systems biology promise new insights into dynamic metabolism, offering potential biomarkers, therapeutic targets, and personalized medicine.

Citations

Citations to this article as recorded by  
  • Development and validation of an interpretable machine learning model for predicting intraoperative HDI in PPGL based on intratumoral and peritumoral CT radiomics
    Shurong Li, Zhiqiang Zhang, Yubing Zhang, Yulong Chen, Jian Ling, Qingfen Hong, Xuanling Wu, Fufu Zheng, Cheng Luo
    European Journal of Radiology.2026; 195: 112559.     CrossRef
  • Features of bioenergetic metabolism in physiological and pathological conditions: focus on oncogenesis
    A. S. Zhdanova, Z. E. Belaya, G. A. Melnichenko
    Problems of Endocrinology.2026; 71(6): 56.     CrossRef
  • Factors Associated with the Development of Skin Lesions in Hospitalized Patients Admitted to a Nursing Preventive Care Program in Colombia
    Gaby E. Escobar, Ángela F Espinosa, Olga L. Cortés, Nicolás Molano González
    Investigación y Educación en Enfermería.2025;[Epub]     CrossRef
  • Editorial: Tumor metabolism and programmed cell death
    Dan-Lan Pu, Qi-Nan Wu
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Molecular subtypes of clear cell renal carcinoma based on PCD-related long non-coding RNAs expression: insights into the underlying mechanisms and therapeutic strategies
    Han Wang, Yang Liu, Aifa Tang, Xiansheng Zhang
    European Journal of Medical Research.2024;[Epub]     CrossRef
Close layer
Brief Report
Adrenal Gland
Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma
Jiyeon Ahn, Ji Yun Park, Gyuri Kim, Sang-Man Jin, Kyu Yeon Hur, Soo-Youn Lee, Jae Hyeon Kim
Endocrinol Metab. 2021;36(3):697-701.   Published online June 1, 2021
DOI: https://doi.org/10.3803/EnM.2020.925
  • 11,578 View
  • 256 Download
  • 6 Web of Science
  • 6 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Pheochromocytoma and paraganglioma (PPGL) is diagnosed through biochemical confirmation of excessive catecholamines in urine and plasma. Recent technological developments have allowed us to measure urinary free metanephrines; however, the diagnostic accuracy of these new methods and the diagnostic cutoff values have not been evaluated.
Methods
This is a retrospective study of 595 subjects, including 71 PPGL cases and 524 controls. PPGL was based on pathological confirmation. Subjects with no evidence of PPGL over 2 years were included in the control group.
Results
Urinary free metanephrines yielded similar area under the curve (AUC) to urinary fractionated metanephrines and plasma free metanephrines. However, urinary free normetanephrine yielded a better AUC than did urinary fractionated normetanephrine. The optimal cutoff for urinary free metanephrine and normetanephrine corrected for urinary creatinine yielded 97.2% sensitivity and 98.1% specificity.
Conclusion
Urinary free metanephrines are a reliable method for diagnosing PPGL in Asian populations compared with existing biochemical methods.

Citations

Citations to this article as recorded by  
  • The Effect of Dietary Lemon Intake on Organic Acids in Morning Urine
    Wen Xiao, Yan Lu, Liping Wu, Lianwen Zhang, Yufan Hui, Hongmin Luo, Jing Li, Jiangtao Yang
    Molecular Nutrition & Food Research.2026;[Epub]     CrossRef
  • Advancements in understanding the molecular mechanisms and clinical implications of Von Hippel-Lindau syndrome: A comprehensive review
    Yaochun Wang, Jingzhuo Song, Shuxing Zheng, Shuhong Wang
    Translational Oncology.2025; 51: 102193.     CrossRef
  • The role of the adrenalectomy in the management of pheochromocytoma: the experience of a Portuguese referral center
    Inês Costa Carvalho, Miguel V. B. Machado, João P. Morais, Filipa Carvalho, Elisabete Barbosa, José Barbosa
    Endocrine.2024; 86(1): 409.     CrossRef
  • Laparoscopic Resection of Para-Aortic Mass at the Aortic Bifurcation: An Atypical Presentation of a Tailgut Cyst
    Andy Wang, Jiddu A Guart, Danielle Li, Trenton Taros, Hongyi Cui
    Cureus.2024;[Epub]     CrossRef
  • Biochemical Assessment of Pheochromocytoma and Paraganglioma
    Graeme Eisenhofer, Christina Pamporaki, Jacques W M Lenders
    Endocrine Reviews.2023; 44(5): 862.     CrossRef
  • Adrenal bleeding due to pheochromocytoma - A call for algorithm
    Ewelina Rzepka, Joanna Kokoszka, Anna Grochowska, Magdalena Ulatowska-Białas, Martyna Lech, Marta Opalińska, Elwira Przybylik-Mazurek, Aleksandra Gilis-Januszewska, Alicja Hubalewska-Dydejczyk
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
Close layer
Special Article
Adrenal gland
Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force
Eu Jeong Ku, Kyoung Jin Kim, Jung Hee Kim, Mi Kyung Kim, Chang Ho Ahn, Kyung Ae Lee, Seung Hun Lee, You-Bin Lee, Kyeong Hye Park, Yun Mi Choi, Namki Hong, A Ram Hong, Sang-Wook Kang, Byung Kwan Park, Moon-Woo Seong, Myungshin Kim, Kyeong Cheon Jung, Chan Kwon Jung, Young Seok Cho, Jin Chul Paeng, Jae Hyeon Kim, Ohk-Hyun Ryu, Yumie Rhee, Chong Hwa Kim, Eun Jig Lee
Endocrinol Metab. 2021;36(2):322-338.   Published online April 6, 2021
DOI: https://doi.org/10.3803/EnM.2020.908
  • 20,140 View
  • 909 Download
  • 13 Web of Science
  • 19 Crossref
AbstractAbstract PDFPubReader   ePub   
Pheochromocytoma and paraganglioma (PPGLs) are rare catecholamine-secreting neuroendocrine tumors but can be life-threatening. Although most PPGLs are benign, approximately 10% have metastatic potential. Approximately 40% cases are reported as harboring germline mutations. Therefore, timely and accurate diagnosis of PPGLs is crucial. For more than 130 years, clinical, molecular, biochemical, radiological, and pathological investigations have been rapidly advanced in the field of PPGLs. However, performing diagnostic studies to localize lesions and detect metastatic potential can be still challenging and complicated. Furthermore, great progress on genetics has shifted the paradigm of genetic testing of PPGLs. The Korean PPGL task force team consisting of the Korean Endocrine Society, the Korean Surgical Society, the Korean Society of Nuclear Medicine, the Korean Society of Pathologists, and the Korean Society of Laboratory Medicine has developed this position statement focusing on the comprehensive and updated diagnosis for PPGLs.

Citations

Citations to this article as recorded by  
  • Surgical Approaches and Perioperative Outcomes in Mediastinal Paragangliomas: A 20-Year Comprehensive Systematic Review
    Nicola Rotolo, Giorgia Cerretani, Sabrina Casagrande, Elisa Nardecchia, Elena Asteggiano, Alberto Colombo, Luca Filipponi, Filippo Piacentino, Schiorlin Ilaria, Federico Fontana
    Cancers.2026; 18(3): 486.     CrossRef
  • Successful Laparoscopic Resection of a Giant Para-aortic Pheochromocytoma: A Case Report
    Loay Ghalyoun, Diya E Viju, Khadiga Abdelmonem, Fahed S Khdrawe, Joaquin Picazo-Yeste
    Cureus.2025;[Epub]     CrossRef
  • Current Understanding of Carotid Body Paraganglioma Management
    Young-Wook Kim
    Vascular Specialist International.2025;[Epub]     CrossRef
  • PHEOCHROMOCYTOMA AND PARAGANGLIOMA: CLINICAL PICTURE, DIAGNOSIS, TREATMENT, FOLLOW-UP AND PROGNOSIS - A LITERATURE REVIEW
    Dominika Żyła, Kornelia Rojek, Andrzej Zuzak, Katarzyna Zych, Sylwia Koziej, Adam Jakubas, Mateusz Korga, Milena Krawczyk
    International Journal of Innovative Technologies in Social Science.2025;[Epub]     CrossRef
  • A Prospective Comparative Study of 18F-FDOPA PET/CT Versus 123I-MIBG Scintigraphy With SPECT/CT for the Diagnosis of Pheochromocytoma and Paraganglioma
    Changhwan Sung, Hyo Sang Lee, Dong Yun Lee, Yong-il Kim, Jae Eun Kim, Sang Ju Lee, Seung Jun Oh, Tae-Yon Sung, Yu-Mi Lee, Young Hoon Kim, Beom-Jun Kim, Jung-Min Koh, Seung Hun Lee, Jin-Sook Ryu
    Clinical Nuclear Medicine.2024; 49(1): 27.     CrossRef
  • Preoperative prediction of metastatic pheochromocytoma and paraganglioma using clinical, genetic, and biochemical markers: A cohort study
    Seung Shin Park, Chang Ho Ahn, Seunghoo Lee, Woochang Lee, Won Woong Kim, Yu‐Mi Lee, Su Jin Kim, Tae‐Yon Sung, Kyu Eun Lee, Jung Hee Kim, Seung Hun Lee, Jung‐Min Koh
    Journal of Internal Medicine.2024; 296(1): 68.     CrossRef
  • Germline Mutations and Phenotypic Associations in Korean Patients With Pheochromocytoma and Paraganglioma: A Multicenter Study and Literature Review
    Kwan Hoon Jo, Jaewoong Lee, Jaeeun Yoo, Hoon Seok Kim, Eun Sook Kim, Je Ho Han, Yi Sun Jang, Jae-Seung Yun, Jang Won Son, Soon Jib Yoo, Seung Hwan Lee, Dong Jun Lim, Hyuk-Sang Kwon, Seungok Lee, Sungdae Moon, Myungshin Kim
    Annals of Laboratory Medicine.2024; 44(6): 591.     CrossRef
  • Raccomandazioni della lista del GdS-Endocrinologia e Malattie del Metabolismo SIPMeL-Choosing wisely: tiroide, anticorpi anti-tiroide, cortisolo, surrene, vitamina D: aggiornamento 2024
    Romolo M. DORIZZI, Vincenzo BRESCIA, Marina VITILLO, Ottavia PORZIO, Federica D’AURIZIO
    La Rivista Italiana della Medicina di Laboratorio.2024;[Epub]     CrossRef
  • Screening and treatment of endocrine hypertension focusing on adrenal gland disorders: a narrative review
    Seung Min Chung
    Journal of Yeungnam Medical Science.2024; 41(4): 269.     CrossRef
  • Clinical and epidemiological characteristics of patients with pheochromocytoma and retroperitoneal paraganglioma
    D. V. Rebrova, N. V. Vorokhobina
    Meditsinskiy sovet = Medical Council.2024; (16): 206.     CrossRef
  • Evaluation and Management of Bone Health in Patients with Thyroid Diseases: A Position Statement of the Korean Thyroid Association
    A Ram Hong, Ho-Cheol Kang
    Endocrinology and Metabolism.2023; 38(2): 175.     CrossRef
  • Lesion-based indicators predict long-term outcomes of pheochromocytoma and paraganglioma– SIZEPASS
    Helena Hanschell, Salvador Diaz-Cano, Alfredo Blanes, Nadia Talat, Gabriele Galatá, Simon Aylwin, Klaus Martin Schulte
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Interleukin-6-producing paraganglioma as a rare cause of systemic inflammatory response syndrome: a case report
    Yin Young Lee, Seung Min Chung
    Journal of Yeungnam Medical Science.2023; 40(4): 435.     CrossRef
  • (Extremely rare intrapericardial location of paraganglioma)
    Jaroslav Zajíc, Aleš Mokráček, Ladislav Pešl, Jiří Haniš, Dita Schaffelhoferová
    Cor et Vasa.2023; 65(4): 692.     CrossRef
  • A Case of Von Hippel-Lindau Disease With Recurrence of Paraganglioma and No Other Associated Symptoms: The Importance of Genetic Testing and Establishing Follow-Up Policies
    Naoki Okada, Akihiro Shioya, Sumihito Togi, Hiroki Ura, Yo Niida
    Cureus.2023;[Epub]     CrossRef
  • KSNM60 in Nuclear Endocrinology: from the Beginning to the Future
    Chae Moon Hong, Young Jin Jeong, Hae Won Kim, Byeong-Cheol Ahn
    Nuclear Medicine and Molecular Imaging.2022; 56(1): 17.     CrossRef
  • Change of Computed Tomography-Based Body Composition after Adrenalectomy in Patients with Pheochromocytoma
    Yousun Ko, Heeryoel Jeong, Seungwoo Khang, Jeongjin Lee, Kyung Won Kim, Beom-Jun Kim
    Cancers.2022; 14(8): 1967.     CrossRef
  • Evaluation and Management of Bone Health in Patients with Thyroid Diseases: a Position Statement from the Korean Thyroid Association
    A Ram Hong, Hwa Young Ahn, Bu Kyung Kim, Seong Hee Ahn, So Young Park, Min-Hee Kim, Jeongmin Lee, Sun Wook Cho, Ho-Cheol Kang
    International Journal of Thyroidology.2022; 15(1): 1.     CrossRef
  • Pheochromocytoma with Retroperitoneal Metastasis: A Case Report
    建新 崔
    Advances in Clinical Medicine.2021; 11(05): 2239.     CrossRef
Close layer
Original Articles
Clinical Study
Whole Exome Sequencing Identifies Novel Genetic Alterations in Patients with Pheochromocytoma/Paraganglioma
Soo Hyun Seo, Jung Hee Kim, Man Jin Kim, Sung Im Cho, Su Jin Kim, Hyein Kang, Chan Soo Shin, Sung Sup Park, Kyu Eun Lee, Moon-Woo Seong
Endocrinol Metab. 2020;35(4):909-917.   Published online December 23, 2020
DOI: https://doi.org/10.3803/EnM.2020.756
  • 9,244 View
  • 185 Download
  • 12 Web of Science
  • 12 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Pheochromocytoma and paragangliomas (PPGL) are known as tumors with the highest level of heritability, approximately 30% of all cases. Clinical practice guidelines of PPGL recommend genetic testing for germline variants in all patients. In this study, we used whole exome sequencing to identify novel causative variants associated with PPGL to improve the detection of rare genetic variants in our cohort.
Methods
Thirty-six tested negative for pathogenic variants in previous Sanger sequencing or targeted gene panel testing for PPGL underwent whole exome sequencing. Whole exome sequencing was performed using DNA samples enriched using TruSeq Custom Enrichment Kit and sequenced with MiSeq (Illumina Inc.). Sequencing alignment and variant calling were performed using SAMtools.
Results
Among previously mutation undetected 36 patients, two likely pathogenic variants and 13 variants of uncertain significance (VUS) were detected in 32 pheochromocytoma-related genes. SDHA c.778G>A (p.Gly260Arg) was detected in a patient with head and neck paraganglioma, and KIF1B c.2787-2A>C in a patient with a bladder paraganglioma. Additionally, a likely pathogenic variant in BRCA2, VUS in TP53, and VUS in NFU1 were detected.
Conclusion
Exome sequencing further identified genetic alterations by 5.6% in previously mutation undetected patients in PPGL. Implementation of targeted gene sequencing consisted of extended genes of PPGL in routine clinical screening can support the level of comprehensive patient assessment.

Citations

Citations to this article as recorded by  
  • Metastatic Pheochromocytoma in a Patient With Li-Fraumeni Syndrome
    Sotiris Loizidis, Christiana Matthaiou, Efrosini Iacovou, Karel Pacak, Ashley Grossman
    JCEM Case Reports.2025;[Epub]     CrossRef
  • Bilateral Pheochromocytoma in a BRCA2 Carrier: Coincidence or Emerging Association?
    Poovarasan S, Shahrukh Memon, Rudrakshi Mahaldar, Saurabh Raj
    Case Reports in Oncology.2025; 18(1): 1247.     CrossRef
  • Patient Sex and Origin Influence Distribution of Driver Genes and Clinical Presentation of Paraganglioma
    Susan Richter, Nicole Bechmann
    Journal of the Endocrine Society.2024;[Epub]     CrossRef
  • Germline Mutations and Phenotypic Associations in Korean Patients With Pheochromocytoma and Paraganglioma: A Multicenter Study and Literature Review
    Kwan Hoon Jo, Jaewoong Lee, Jaeeun Yoo, Hoon Seok Kim, Eun Sook Kim, Je Ho Han, Yi Sun Jang, Jae-Seung Yun, Jang Won Son, Soon Jib Yoo, Seung Hwan Lee, Dong Jun Lim, Hyuk-Sang Kwon, Seungok Lee, Sungdae Moon, Myungshin Kim
    Annals of Laboratory Medicine.2024; 44(6): 591.     CrossRef
  • Clinical exome next‑generation sequencing panel for hereditary pheochromocytoma and paraganglioma diagnosis
    Beatrice Melli, Vincenza Cusenza, Sandra Martinelli, Federica Castiglione, Loretta Fornaciari, Andrea Palicelli, Luca Braglia, Enrico Farnetti, Aurelio Negro, Simonetta Rosato, Andrea Frasoldati, Maicol Baldini, Chiara Grasselli, Davide Nicoli
    Experimental and Therapeutic Medicine.2024;[Epub]     CrossRef
  • Case Report: Aggressive neural crest tumors in a child with familial von Hippel Lindau syndrome associated with a germline VHL mutation (c.414A>G) and a novel KIF1B gene mutation
    Lucie Landen, Anne De Leener, Manon Le Roux, Bénédicte Brichard, Selda Aydin, Dominique Maiter, Philippe A. Lysy
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • A Case of Pheochromocytoma as a Subsequent Neoplasm in a Survivor of Childhood Embryonal Rhabdomyosarcoma
    Rozalyn L. Rodwin, Sanyukta K. Janardan, Erin W. Hofstatter, Nina S. Kadan-Lottick
    Journal of Pediatric Hematology/Oncology.2022; 44(2): e585.     CrossRef
  • Mutations of 1p genes do not consistently abrogate tumor suppressor functions in 1p-intact neuroblastoma
    Chik Hong Kuick, Jia Ying Tan, Deborah Jasmine, Tohari Sumanty, Alvin Y. J. Ng, Byrrappa Venkatesh, Huiyi Chen, Eva Loh, Sudhanshi Jain, Wan Yi Seow, Eileen H. Q. Ng, Derrick W. Q. Lian, Shui Yen Soh, Kenneth T. E. Chang, Zhi Xiong Chen, Amos H. P. Loh
    BMC Cancer.2022;[Epub]     CrossRef
  • A case of juvenile-onset pheochromocytoma with KIF1B p.V1529M germline mutation
    Masahiro Nezu, Yosuke Hirotsu, Kenji Amemiya, Miho Katsumata, Tomomi Watanabe, Soichi Takizawa, Masaharu Inoue, Hitoshi Mochizuki, Kyoko Hosaka, Toshio Oyama, Masao Omata
    Endocrine Journal.2022; 69(6): 705.     CrossRef
  • Systematic analysis of expression profiles and prognostic significance for MMDS-related iron–sulfur proteins in renal clear cell carcinoma
    Ling Yang, Yu-Xin Chen, Ying-Ying Li, Xiao-Juan Liu, Yong-Mei Jiang, Jia Mai
    Scientific Reports.2022;[Epub]     CrossRef
  • Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force
    Eu Jeong Ku, Kyoung Jin Kim, Jung Hee Kim, Mi Kyung Kim, Chang Ho Ahn, Kyung Ae Lee, Seung Hun Lee, You-Bin Lee, Kyeong Hye Park, Yun Mi Choi, Namki Hong, A Ram Hong, Sang-Wook Kang, Byung Kwan Park, Moon-Woo Seong, Myungshin Kim, Kyeong Cheon Jung, Chan
    Endocrinology and Metabolism.2021; 36(2): 322.     CrossRef
  • Recurrent Germline Mutations of CHEK2 as a New Susceptibility Gene in Patients with Pheochromocytomas and Paragangliomas
    Yinjie Gao, Chao Ling, Xiaosen Ma, Huiping Wang, Yunying Cui, Min Nie, Anli Tong, Dario De Biase
    International Journal of Endocrinology.2021; 2021: 1.     CrossRef
Close layer
Clinical Study
Genetic Analysis and Clinical Characteristics of Hereditary Pheochromocytoma and Paraganglioma Syndrome in Korean Population
Heewon Choi, Kyoung Jin Kim, Namki Hong, Saeam Shin, Jong-Rak Choi, Sang Wook Kang, Seung Tae Lee, Yumie Rhee
Endocrinol Metab. 2020;35(4):858-872.   Published online December 23, 2020
DOI: https://doi.org/10.3803/EnM.2020.683
  • 9,485 View
  • 227 Download
  • 15 Web of Science
  • 16 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Pheochromocytoma and paragangliomas (PPGL) are hereditary in approximately 30% to 40% cases. With the advancement of genetic analysis techniques, including next-generation sequencing (NGS), there were attempts to classify PPGL into molecular clusters. With NGS being applied to clinical settings recently, we aimed to review the results of genetic analysis, including NGS, and investigate the association with clinical characteristics in Korean PPGL patients.
Methods
We reviewed the medical records of PPGL patients who visited Severance hospital from 2006 to 2019. We documented the clinical phenotype of those who underwent targeted NGS or had known germline mutations of related genes.
Results
Among 57 PPGL patients, we found 28 pathogenic germline mutations of susceptibility genes. Before the targeted NGS was implemented, only obvious syndromic feature lead to the Sanger sequencing for the specific genes. Therefore, for the exact prevalence, only patients after the year 2017, when targeted NGS was added, were included (n=43). The positive germline mutations were found in 14 patients; thus, the incidence rate is 32.6%. Patients with germline mutations had a higher likelihood of family history. There were significant differences in the type of PPGLs, percentage of family history, metastasis rate, presence of other tumors, and biochemical profile among three molecular clusters: pseudohypoxic tricarboxylic acid cycle-related, pseudohypoxic von Hippel-Lindau (VHL)/endothelial PAS domain-containing protein 1-related, and kinase-signaling group. Germline mutations were identified in seven PPGL-related genes (SDHB, RET, VHL, NF1, MAX, SDHA, and SDHD).
Conclusion
We report the expected prevalence of germline mutations in Korean PPGL patients. NGS is a useful and accessible tool for genetic analysis in patients with PPGLs, and further research on molecular classification is needed for precise management.

Citations

Citations to this article as recorded by  
  • Clinical and Genetic Characteristics of Pheochromocytoma and Paraganglioma: A Single-Center Experience Including a Rare VHL Variant
    Merve Korkmaz Yilmaz, Ozlem Kandemir Alibakan, Aydeniz Aydin Gumus, Alper Gezdirici, Huseyin Karatay, Serkan Sari, Tugba Matlim Ozel, Mutlu Niyazoglu, Esra Hatipoglu
    Journal of Clinical Medicine.2026; 15(2): 712.     CrossRef
  • Carotid body tumors—epidemiology and surgical resection
    Kiyoto Shiga, Katsunori Katagiri, Aya Ikeda, Daisuke Saito, Shin-ichi Oikawa, Kodai Tshuchida, Jun Miyaguchi, Takahiro Kusaka, Akio Tamura
    Japanese Journal of Clinical Oncology.2025; 55(8): 852.     CrossRef
  • A Family case of von Hippel-Lindau syndrome
    R. A. Atanesyan, L. Y. Klimov, T. M. Vdovina, G. A. Saneeva, E. I. Andreeva, I. K. Gasparian
    Problems of Endocrinology.2025; 71(5): 68.     CrossRef
  • Patient Sex and Origin Influence Distribution of Driver Genes and Clinical Presentation of Paraganglioma
    Susan Richter, Nicole Bechmann
    Journal of the Endocrine Society.2024;[Epub]     CrossRef
  • Main mechanisms and clinical implications of alterations in energy expenditure state among patients with pheochromocytoma and paraganglioma: A review
    Yuqi Yang, Tong Zhou, Xue Zhao, Yunjia Cai, Yao Xu, Xiaokun Gang, Guixia Wang
    Medicine.2024; 103(17): e37916.     CrossRef
  • Validation and Evaluation of 5 Scoring Systems for Predicting Metastatic Risk in Pheochromocytoma and Paraganglioma
    Qin Li, Zhigang Lan, Yong Jiang, Rui Wang, Ziyao Li, Xiaolin Jiang
    American Journal of Surgical Pathology.2024; 48(7): 855.     CrossRef
  • Differences between Patients with Sporadic and Familial Pheochromocytoma—Is It Possible to Avoid Genetic Testing in Certain Patients?
    María Consuelo Muñoz, Beatriz Febrero, Miriam Abellán, Antonio Miguel Hernández, José Manuel Rodríguez
    Biomedicines.2024; 12(6): 1352.     CrossRef
  • Germline Mutations and Phenotypic Associations in Korean Patients With Pheochromocytoma and Paraganglioma: A Multicenter Study and Literature Review
    Kwan Hoon Jo, Jaewoong Lee, Jaeeun Yoo, Hoon Seok Kim, Eun Sook Kim, Je Ho Han, Yi Sun Jang, Jae-Seung Yun, Jang Won Son, Soon Jib Yoo, Seung Hwan Lee, Dong Jun Lim, Hyuk-Sang Kwon, Seungok Lee, Sungdae Moon, Myungshin Kim
    Annals of Laboratory Medicine.2024; 44(6): 591.     CrossRef
  • Genotype and clinical phenotype characteristics of MAX germline mutation–associated pheochromocytoma/paraganglioma syndrome
    Bijun Lian, Jun Lu, Xudong Fang, Yiming Zhang, Wei Wang, Yi He, Hongyuan Yu, Feiping Li, Junwei Wang, Weiying Chen, Xiaoping Qi
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Novel and recurrent genetic variants of VHL, SDHB, and RET genes in Chinese pheochromocytoma and paraganglioma patients
    Chong Li, Jingyi Li, Chao Han, Ting Wang, Lixia Zhang, Zhifang Wang, Tingting Wang, Lijun Xu, Guangzhao Qi, Guijun Qin, Xialian Li, Lili Zheng
    Frontiers in Genetics.2023;[Epub]     CrossRef
  • Genetic Study in Pheochromocytoma: Is It Possible to Stratify the Risk of Hereditary Pheochromocytoma?
    Marta Araujo-Castro, César Mínguez Ojeda, Iñigo García Sanz, Maria Calatayud, Felicia Hanzu, Mireia Mora, Almudena Vicente, Concepción Blanco Carrera, Paz de Miguel Novoa, María del Carmen López García, Cristina Lamas, Laura Manjón-Miguélez, María del Cas
    Neuroendocrinology.2023; 113(6): 657.     CrossRef
  • The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis
    Petra Hudler, Mojca Urbancic
    Genes.2022; 13(2): 362.     CrossRef
  • Bilateral Pheochromocytoma with Germline MAX Variant without Family History
    Shinnosuke Hata, Mai Asano, Hiroyuki Tominaga, Masahide Hamaguchi, Fumiya Hongo, Takeshi Usui, Eiichi Konishi, Michiaki Fukui
    Clinics and Practice.2022; 12(3): 299.     CrossRef
  • Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force
    Eu Jeong Ku, Kyoung Jin Kim, Jung Hee Kim, Mi Kyung Kim, Chang Ho Ahn, Kyung Ae Lee, Seung Hun Lee, You-Bin Lee, Kyeong Hye Park, Yun Mi Choi, Namki Hong, A Ram Hong, Sang-Wook Kang, Byung Kwan Park, Moon-Woo Seong, Myungshin Kim, Kyeong Cheon Jung, Chan
    Endocrinology and Metabolism.2021; 36(2): 322.     CrossRef
  • Prevalence of Germline Variants in a Large Cohort of Japanese Patients with Pheochromocytoma and/or Paraganglioma
    Masato Yonamine, Koichiro Wasano, Yuichi Aita, Takehito Sugasawa, Katsutoshi Takahashi, Yasushi Kawakami, Hitoshi Shimano, Hiroyuki Nishiyama, Hisato Hara, Mitsuhide Naruse, Takahiro Okamoto, Tadashi Matsuda, Shinji Kosugi, Kazuhiko Horiguchi, Akiyo Tanab
    Cancers.2021; 13(16): 4014.     CrossRef
  • Recurrent Germline Mutations of CHEK2 as a New Susceptibility Gene in Patients with Pheochromocytomas and Paragangliomas
    Yinjie Gao, Chao Ling, Xiaosen Ma, Huiping Wang, Yunying Cui, Min Nie, Anli Tong, Dario De Biase
    International Journal of Endocrinology.2021; 2021: 1.     CrossRef
Close layer
Clinical Study
Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service
Jung Hee Kim, Hyemi Moon, Junghyun Noh, Juneyoung Lee, Sin Gon Kim
Endocrinol Metab. 2020;35(1):157-164.   Published online March 19, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.1.157
  • 12,653 View
  • 226 Download
  • 37 Web of Science
  • 34 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Pheochromocytomas and paragangliomas (PPGLs) are rare endocrine tumors originating from chromaffin cells. PPGLs are associated with a high mortality rate and several complications. To date, no epidemiological studies have been conducted on PPGLs in Asia. This study aimed to investigate the epidemiology and prognosis of PPGLs in Korea using nationwide data.

Methods

Using the National Health Insurance Service Database, subjects with a principal diagnosis of PPGLs on two or more occasions between 2003 and 2014 who satisfied the operational definition of PPGLs were included. Incidence, prevalence, complications, metastasis, and mortality were investigated.

Results

In total, 1048 subjects with a mean age of 47.6±16.1 years were included. There was no sex preponderance. The overall prevalence of PPGLs was 2.13 per 100,000 persons, and the overall age-standardized incidence rate was 0.18 per 100,000 person-years. Malignant PPGLs accounted for 17.7% (185 of 1,048) of cases, and 94 subjects exhibited metastasis at the time of diagnosis. Among initially non-metastatic PPGLs, 9.5% (nine of 954) eventually metastasized after a mean duration of 78.1±41.4 months. The 5-year survival rates for non-metastatic and metastatic PPGLs at diagnosis were 97% and 84%, respectively. Multivariable Cox regression models adjusted for covariates showed that metastatic PPGLs were associated with a 2.40-fold higher risk of mortality than non-metastatic PPGLs (95% confidence interval, 1.38 to 4.17; P=0.002).

Conclusion

PPGLs are rare in Korea, and the prognosis of these endocrine tumors varies depending on whether they are benign or malignant. This epidemiological study paves the way for further research on PPGLs.

Citations

Citations to this article as recorded by  
  • Digital Phenotyping of Rare Endocrine Diseases Across International Data Networks and the Effect of Granularity of Original Vocabulary
    Seunghyun Lee, Namki Hong, Gyu Seop Kim, Jing Li, Xiaoyu Lin, Sarah Seager, Sungjae Shin, Kyoung Jin Kim, Jae Hyun Bae, Seng Chan You, Yumie Rhee, Sin Gon Kim
    Yonsei Medical Journal.2025; 66(3): 187.     CrossRef
  • Prediction of postoperative myocardial injury in patients undergoing laparoscopic pheochromocytoma/paraganglioma resection: protocol for an ambispective cohort study
    Ling Lan, Ye Ma, Yifei Zhao, Yaohan Li, Yi Zhang, Le Shen, Yuelun Zhang, Yuguang Huang
    BMJ Open.2025; 15(2): e091975.     CrossRef
  • Elevated Fracture Risks in Patients Using Inhaled Corticosteroids: A Korean Nationwide Study
    Sung Hye Kong, Ae Jeong Jo, Chan Mi Park, Kyun Ik Park, Ji Eun Yun, Jung Hee Kim
    Endocrinology and Metabolism.2025; 40(1): 82.     CrossRef
  • Differences in Clinical Presentation Between Pheochromocytomas and Paragangliomas
    Vincent E. D. Pihlblad, Jan Calissendorff, Henrik Falhammar
    Clinical Endocrinology.2025; 103(5): 651.     CrossRef
  • The effect of primary tumor resection on overall survival in metastatic pheochromocytoma and paraganglioma: A population-based study
    Hexiang Bai, Zhihong Liu, Xu Liu, Yige Jia, Yuchun Zhu, Xiang Li, Kan Wu
    Surgery.2025; 187: 109637.     CrossRef
  • Pheochromocytoma-Induced Leukocytosis With Concurrent Severe Eosinophilia: A Case Report
    Nouf Alnaqeeb, Mohamed M Abd Elhamid, Ihab AImagdub, Randa Ali
    Cureus.2025;[Epub]     CrossRef
  • Analysis of the clinical characteristics of bone metastases after pheochromocytoma/paraganglioma surgery
    Longmin Li, Hongbo Gao, Yujun Shao, Xiayang Zhu
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Preoperative prediction of metastatic pheochromocytoma and paraganglioma using clinical, genetic, and biochemical markers: A cohort study
    Seung Shin Park, Chang Ho Ahn, Seunghoo Lee, Woochang Lee, Won Woong Kim, Yu‐Mi Lee, Su Jin Kim, Tae‐Yon Sung, Kyu Eun Lee, Jung Hee Kim, Seung Hun Lee, Jung‐Min Koh
    Journal of Internal Medicine.2024; 296(1): 68.     CrossRef
  • Seventy years of pheochromocytomas and paragangliomas in Argentina. The FRENAR database
    V.C. de Miguel, L.S. Aparicio, G. Sansó, A.L. Paissan, S.N. Lupi, S.H. Belli, J. Tkatch, M.J. Marín, M.B. Barontini
    Hipertensión y Riesgo Vascular.2024; 41(3): 170.     CrossRef
  • Metastatic disease and major adverse cardiovascular events preceding diagnosis are the main determinants of disease-specific survival of pheochromocytoma/paraganglioma: long-term follow-up of 303 patients
    Wolfgang Raber, Raphael Schendl, Melisa Arikan, Andreas Scheuba, Peter Mazal, Valerie Stadlmann, Reinhard Lehner, Petra Zeitlhofer, Sabina Baumgartner-Parzer, Cornelia Gabler, Harald Esterbauer
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Big Data Research in the Field of Endocrine Diseases Using the Korean National Health Information Database
    Sun Wook Cho, Jung Hee Kim, Han Seok Choi, Hwa Young Ahn, Mee Kyoung Kim, Eun Jung Rhee
    Endocrinology and Metabolism.2023; 38(1): 10.     CrossRef
  • Diagnosis and Management of Pheochromocytomas and Paragangliomas: A Guide for the Clinician
    Sona Sharma, Lauren Fishbein
    Endocrine Practice.2023; 29(12): 999.     CrossRef
  • Pheochromocytoma: a changing perspective and current concepts
    Andreas Kiriakopoulos, Periklis Giannakis, Evangelos Menenakos
    Therapeutic Advances in Endocrinology and Metabolism.2023;[Epub]     CrossRef
  • Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas
    Gildas Gabiache, Charline Zadro, Laura Rozenblum, Delphine Vezzosi, Céline Mouly, Matthieu Thoulouzan, Rosine Guimbaud, Philippe Otal, Lawrence Dierickx, Hervé Rousseau, Christopher Trepanier, Laurent Dercle, Fatima-Zohra Mokrane
    Cancers.2023; 15(18): 4666.     CrossRef
  • Trends in the incidence of adrenocortical carcinoma and pheochromocytoma/paraganglioma in Taiwan
    Chung-Hsin Tsai, Tun-Sung Huang, Shih-Ping Cheng
    Formosan Journal of Surgery.2023; 56(5): 147.     CrossRef
  • An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma
    Anri Inaki, Tohru Shiga, Yoshito Tsushima, Megumi Jinguji, Hiroshi Wakabayashi, Daiki Kayano, Norihito Akatani, Takafumi Yamase, Yuji Kunita, Satoru Watanabe, Tomo Hiromasa, Hiroshi Mori, Kenji Hirata, Shiro Watanabe, Tetsuya Higuchi, Hiroyasu Tomonaga, S
    Annals of Nuclear Medicine.2022; 36(3): 267.     CrossRef
  • Pheochromocytomas and Abdominal Paragangliomas: A Practical Guidance
    Jan Calissendorff, Carl Christofer Juhlin, Irina Bancos, Henrik Falhammar
    Cancers.2022; 14(4): 917.     CrossRef
  • Characteristics of Intraoperative Hemodynamic Instability in Postoperatively Diagnosed Pheochromocytoma and Sympathetic Paraganglioma Patients
    Jung Hee Kim, Hyung-Chul Lee, Su-jin Kim, Kyu Eun Lee, Kyeong Cheon Jung
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Change of Computed Tomography-Based Body Composition after Adrenalectomy in Patients with Pheochromocytoma
    Yousun Ko, Heeryoel Jeong, Seungwoo Khang, Jeongjin Lee, Kyung Won Kim, Beom-Jun Kim
    Cancers.2022; 14(8): 1967.     CrossRef
  • Systematic Review: Incidence of Pheochromocytoma and Paraganglioma Over 70 Years
    Abdul Rahman Al Subhi, Veronica Boyle, Marianne S Elston
    Journal of the Endocrine Society.2022;[Epub]     CrossRef
  • Incidence and risk factors for myocardial injury after laparoscopic adrenalectomy for pheochromocytoma: A retrospective cohort study
    Ling Lan, Qian Shu, Chunhua Yu, Lijian Pei, Yuelun Zhang, Li Xu, Yuguang Huang
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • The Clinical Characteristics of Pheochromocytomas and Paragangliomas with Negative Catecholamines
    Lin Zhao, Xiaoran Zhang, Xu Meng, Ting Zhang, Hua Fan, Qiongyu Zhang, Yecheng Liu, Xianliang Zhou, Huadong Zhu
    Journal of Clinical Medicine.2022; 11(19): 5583.     CrossRef
  • A midline ectopic paraganglioma
    Christina SANT FOURNIER, Matthias FARRUGIA, Kimberley PACE, Christian CAMENZULI, Alexander R. ATTARD
    Chirurgia.2022;[Epub]     CrossRef
  • Non-Selective Alpha-Blockers Provide More Stable Intraoperative Hemodynamic Control Compared with Selective Alpha1-Blockers in Patients with Pheochromocytoma and Paraganglioma: A Single-Center Retrospective Cohort Study with a Propensity Score-Matched Ana
    Yang Yang, Jie Zhang, Liqun Fang, Xue Jia, Wensheng Zhang
    Drug Design, Development and Therapy.2022; Volume 16: 3599.     CrossRef
  • Incidence and Clinical Presentation of Pheochromocytoma and Sympathetic Paraganglioma: A Population-based Study
    Andreas Ebbehoj, Kirstine Stochholm, Sarah Forslund Jacobsen, Christian Trolle, Peter Jepsen, Maciej Grzegorz Robaczyk, Åse Krogh Rasmussen, Ulla Feldt-Rasmussen, Reimar Wernich Thomsen, Esben Søndergaard, Per Løgstrup Poulsen
    The Journal of Clinical Endocrinology & Metabolism.2021; 106(5): e2251.     CrossRef
  • Determinants of anxiety and depression among pheochromocytoma patients
    Siming Jia, Chengbai Li, Zhuqing Lei, Qiang Xia, Yuqing Jiang
    Medicine.2021; 100(3): e24335.     CrossRef
  • Pheochromocytoma and paraganglioma with negative results for urinary metanephrines show higher risks for metastatic diseases
    Akiyuki Kawashima, Masakatsu Sone, Nobuya Inagaki, Kentaro Okamoto, Mika Tsuiki, Shoichiro Izawa, Michio Otsuki, Shintaro Okamura, Takamasa Ichijo, Takuyuki Katabami, Yoshiyu Takeda, Takanobu Yoshimoto, Mitsuhide Naruse, Akiyo Tanabe
    Endocrine.2021; 74(1): 155.     CrossRef
  • Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force
    Eu Jeong Ku, Kyoung Jin Kim, Jung Hee Kim, Mi Kyung Kim, Chang Ho Ahn, Kyung Ae Lee, Seung Hun Lee, You-Bin Lee, Kyeong Hye Park, Yun Mi Choi, Namki Hong, A Ram Hong, Sang-Wook Kang, Byung Kwan Park, Moon-Woo Seong, Myungshin Kim, Kyeong Cheon Jung, Chan
    Endocrinology and Metabolism.2021; 36(2): 322.     CrossRef
  • Clinical Presentation and Perioperative Management of Pheochromocytomas and Paragangliomas: A 4-Decade Experience
    Thomas Uslar, Ignacio F San Francisco, Roberto Olmos, Stefano Macchiavelo, Alvaro Zuñiga, Pablo Rojas, Marcelo Garrido, Alvaro Huete, Gonzalo P Mendez, Ignacio Cortinez, José Tomás Zemelman, Joaquín Cifuentes, Fernando Castro, Daniela Olivari, José Miguel
    Journal of the Endocrine Society.2021;[Epub]     CrossRef
  • Pheochromocytoma
    Zhonghua Liu, Junsheng Ma, Camilo Jimenez, Miao Zhang
    American Journal of Surgical Pathology.2021; 45(9): 1155.     CrossRef
  • Perioperative hemodynamic instability in pheochromocytoma and sympathetic paraganglioma patients
    Jung Hee Kim, Hyung-Chul Lee, Su-jin Kim, Soo Bin Yoon, Sung Hye Kong, Hyeong Won Yu, Young Jun Chai, June Young Choi, Kyu Eun Lee, Kwang-Woong Lee, Seung-Kee Min, Chan Soo Shin, Kyu Joo Park
    Scientific Reports.2021;[Epub]     CrossRef
  • Changes in the Nociception Level Index During Surgical Resection of Paragangliomas: A Case Report
    Rita Saynhalath, Umar H. Khan, Gijo Alex, Joseph T. Murphy, Peter Szmuk
    A&A Practice.2021; 15(11): e01542.     CrossRef
  • Hypertension Cure and Reducing Pill Burden after Adrenalectomy for Endocrine Hypertension of Adrenal Origin: A Comparative Study from an Asian and UK Cohort
    Kee Y Ngiam, Ciaran Durand, Titus C Vasciuc, Chia H Tai, Raluca Orpean, Fiona Eatock, Mehak Mahipal, Tan W Boon
    World Journal of Endocrine Surgery.2021; 13(1): 9.     CrossRef
  • A Brief Overview of the Epidemiology of Pheochromocytoma and Paraganglioma in Korea
    Yun Mi Choi
    Endocrinology and Metabolism.2020; 35(1): 95.     CrossRef
Close layer
Case Reports
A Case of Calcitonin Secreting Pheochromocytoma.
Joo Won Byun, Young Goo Shin, Choon Hee Chung, Young Jun Won, Yoon Jong Choi, Eui Ryun Park, Mi Duck Lee, Chang Ho Song, Mi Youn Cho, Sung Jun Kang
J Korean Endocr Soc. 1996;11(3):343-347.   Published online November 7, 2019
  • 2,105 View
  • 37 Download
AbstractAbstract PDF
Pheochromocytoma is a catecholamine producing turnor and raise with less than 0.1% of hypertensive patients. It is developed, most commonly, in sporadic pheochromocytoma or multiple endocrine neoplasia type 2. Therefore, when hypercalcitoninemia is found in a patient with pheochromocytoma, the possibility of multiple endocrine neoplasia type 2 or the ectopic secretion of calcitonin must be considered. Recently we experienced a 45 year old male patient with sporadic pheochrornocytoma. He also had hypercalcitoninemia and normocalcemia. After the removal of pheochromocytoma, serum calcitnnin level returned to normal. Secretion of calcitonin was confirmed by immunohisto- chemical stain.
Close layer
Nerepinephrine Secreting Pheochromocytoma in the Organ of Zuckerkandl With Epinephrine Granules in Cytoplasm.
Eui Suk Kim, Gang Ryong Lee, Won Seok Lee, Jeong Aa Lee, Jie Jeong Jang, In Cheol Sunwoo, Dae Ha Kim, Gwang Seob Lee
J Korean Endocr Soc. 1996;11(2):233-239.   Published online November 7, 2019
  • 1,674 View
  • 19 Download
AbstractAbstract PDF
Extraadrenal pheochromocytomas developed from the paraganglia other than adrenal medulla are uncommon tumors. Such lesions have been reported that as much as 10% of retroperitoneal paragliomas arise outside the adrenal gland. But their incidence and prognosis are changing partly as a result of progression in developmental mechanism, diagnostic tools and concepts including ultrastructure, immunohistochemistry. The ultrastructure of chromaffine neoplasm from adrenal and extraadrenal tissues has been studied with chrarnaffine granule specificity and type of catecholamine content. With rare exceptions, extraadrenal chrornaffine tumor mainly has high concentration of norepinephrine which is suggested as dict relationship to numoruos electrone dense granular bodies in the cell cytoplasrn. High or intermediate level of epinephrine in tissue is associated with cytoplasmic granular bodies of much less density, Recently we experienced the exception, a case of norepinephrine secreting pheochrom-ocytoma in the organ of Zuckerkandl with epinephrine granules in cytoplasm and this discrepancy probably due to the plasticity - the differences in developmental process and local factors between adrenal medulla and extraadrenal tissues.
Close layer
A Case of Multiple Extraadrenal Pheochromocytoma Iocalized by 131 I-MIBG Scan.
Sung Hee Ihm, Jae Myung Yoo, Moon Gi Choi, Hyung Joon Yoo, Seok Boo Yoon, Jin Bong Kim, Doo Man Kim, Jin Seon Cho, Sang Kon Lee, Sung Woo Park
J Korean Endocr Soc. 1995;10(4):439-444.   Published online November 7, 2019
  • 1,768 View
  • 19 Download
AbstractAbstract PDF
Peroperative localization of pheochromocytoma is the very crucial step for the successful removal of tumors. Computed tomography(CT) and magnetic resonance(MR) imaging have been commonly used for tumor localization, but in some cases of pheochromocytoma, such as extraadrenal location or distant metastasis of malignant tumor, their localization is somewhat difficult. Recently ^131 I-metaiodobenzylguanidine(MIBG) scintigraphy has been developed and increasingly used for the localization of pheochromocytoma and reported to be more sensitive and specific than CT or MR imaging in the cases of extraadrenal tumor location.We report a case of multiple extraadrenal pheochromocytoma in which ^131 I-MIBG scintigraphy clearly localized two intraabdominal and one bladder tumors, after failure of localization with conventional CT and MR imaging.
Close layer
Original Articles
A Clinical Observation of Endocrine Adrenal Tumors.
Hye Young Park, Tae Suk Kim, Soo Jin Lee, Dong Gu Choi, Moon Ho Kang
J Korean Endocr Soc. 1994;9(3):228-238.   Published online November 6, 2019
  • 1,667 View
  • 28 Download
AbstractAbstract PDF
Endocrine adrenal tumors are uncommon but clinically significant because they can be managed successfully by surgical therapy. During pregnancy, adrenal tumors can be a cause of death for both mother and baby, unless they diagnoses antenatally and managed properly. To investigate clinical characteristics of endocrine adrenal tumors, we analyzed 26 cases of adrenal tumor diagnosed and managed in Chung Ang Gil Hospital including cases associated with pregnancy and also a rare case of paraganglioma in liver. 1) There were 7 cases of Cushing's syndrome among which two cases were due to Cushing's disease and five cases were due to adrenal adenoma. Six cases were managed successfully by appropriate surgery. Another one case was associated with pregnancy but the patient expired due to sudden development of pulmonary edema and hypotension during preoperative preparation.2) Among 9 cases of primary aldosteronism, 8 cases were aldosterone-producing adenoma(APA) and 1 case was idiopathic hyperaldosteronism(IHA). In differential diagnosis between APA and IHA, diagnostic accuracy of postural study and adrenal CT was 86%, 78% respectively. In each one case of APA and IHA, adrenal venous aldosterone sampling was used for the differential diagnosis. Six cases of APA were managed by appropriate surgery. One patient with APA who refuses surgery and one patient with IHA were placed on spironolactone with good response.3) Among 10 cases of pheochromocytoma, seven cases were from adrenal gland and three cases were paragangliomas including one case originating from liver and two cases from abdominal ganglia. One patient with pheochromocytoma was diagnosed in 1st trimester of pregnancy and she was successfully treated by surgery.We observed 26 cases of endocrine adrenal tumors which were successfully managed except one case. We think that it is important to pay attention to adrenal tumor for early diagnosis particulary when associated with pregnancy. Paraganglioma in liver, although very rare, should be included in the differential diagnosis of space occupying lesion in liver.
Close layer
Immunohistochemical Study of c - Myc, c - Fos and c - Jun Oncoprotein Expression in the Human Pheochromocytoma.
Jae Wha Jo, Eun Jig Lee, Moon Suk Nam, Kyung Rae Kim, Su Youn Nam, Young Duk Song, Sung Kil Lim, Hyun Chul Lee, Kap Bum Huh, Yong Hye Lee, Tae Seung Kim, Kwan Woo Lee
J Korean Endocr Soc. 1995;10(1):26-34.   Published online November 6, 2019
  • 1,719 View
  • 20 Download
AbstractAbstract PDF
A large number of studies for genes involved in oncogenesis have been done during last decade. Over 20 oncogenes have been isolated characterized, and the oncogene expressions in human tumors have been examined. The proto-oncogenes of c-Myc, c-Fos and c-Jun, which modulate the transcription factors, have overexpressed in a variety of human cancers. Immunohistochemical method was used in this study to examine c-Myc, c-Fos and c-Jun oncoprotein expression in 31 patients with human pheochromocytoma 28(90.0%) were benign and 3(10.0%) malignant. C-Myc oncoprotein immunoreactivity was found in 24 cases(77.4%), c-Fos in 29(93.5%), and c-Jun in 25(80.6%). Twenty-one(67.7%) showed positive immunoreactivity for all these oncoproteins, six(19.4%) for 2 oncoproteins, 3 for one oncoprotein. Only 1 case showed negative immunoreactivity for all 3 oncoproteins. The oncoprotein immunoreactivity did not correlate with the amount of 24 hour urinary catecholamine excretion. Although the number of malignant pheochromocytomsa was not so many, most of them showed that the immunoreactivity for oncoprotein was more than 30 percent of tumor cells.The expression of c-Myc, c-Fos and c-Jun oncoprotein were frequently found in human pheochromocytoma. These results suggest that the oncoprotein expression may play an important role in tumorogenesis and proliferation of human pheochromocytoma.
Close layer
Case Report
A Case of Pheochromocytoma Diagnosed as Preeclampsia during Prenancy.
Bong Yun Cha, Ho Young Son, Soon Jip Yoo, Ki Hyun Baik, Myung Hoon Kim, Moo Il Kang, E Jin Choi, Kwang Woo Lee, Sung Koo Kang, Uk Kim, Jong Man Won, Jin Young Yoo
J Korean Endocr Soc. 1994;10(3):295-299.   Published online November 6, 2019
  • 1,605 View
  • 29 Download
AbstractAbstract PDF
A case of a pregnant woman with an undiagnosed pheochromocytoma is presented. Gestational hypertension was developed at 33 weeks' gestation. Also she experienced intermittent chest discomfort, headache and irritability during those period. Normal vaginal delivery was successfully performed with close observation. Even though experiencing same symptoms for two years after delivery, she had been treated as neurosis. Uncatched pheochromocytoma was detected and the tumor was resected successfully. It seems to be that many cases of pheochromocytoma with pregnancy still go unrecognized because of close similarity between pheochromocytoma and toxemia. High index of suspicion should be maintained to achieve early diagnosis because antenatal diagnosis can lower the mortality in both mother and fetus.
Close layer
Namgok Lecture 2017
Adrenal gland
Bone Health in Adrenal Disorders
Beom-Jun Kim, Seung Hun Lee, Jung-Min Koh
Endocrinol Metab. 2018;33(1):1-8.   Published online March 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.1.1
  • 9,267 View
  • 62 Download
  • 17 Web of Science
  • 16 Crossref
AbstractAbstract PDFPubReader   ePub   

Secondary osteoporosis resulting from specific clinical disorders may be potentially reversible, and thus continuous efforts to find and adequately treat the secondary causes of skeletal fragility are critical to ameliorate fracture risk and to avoid unnecessary treatment with anti-osteoporotic drugs. Among the hyperfunctional adrenal masses, Cushing's syndrome, pheochromocytoma, and primary aldosteronism are receiving particularly great attention due to their high morbidity and mortality mainly by increasing cardiovascular risk. Interestingly, there is accumulating experimental and clinical evidence that adrenal hormones may have direct detrimental effects on bone metabolism as well. Thus, the present review discusses the possibility of adrenal disorders, especially focusing on pheochromocytoma and primary aldosteronism, as secondary causes of osteoporosis.

Citations

Citations to this article as recorded by  
  • A Correlative Study of Bone Metabolism Markers and Primary Aldosteronism
    晓彤 潘
    Advances in Clinical Medicine.2025; 15(05): 656.     CrossRef
  • Exploring the experience and needs of postoperative rehabilitation management for elderly patients with osteoporotic vertebral compression fractures after percutaneous vertebroplasty: a qualitative study
    Wei Kang, Junwei Shi, Yang Long, Li Li, Wei Xu
    BMC Geriatrics.2025;[Epub]     CrossRef
  • Investigating the association between creatinine-adjusted urinary catecholamines and site-specific bone mineral density in older adults
    Laith Ashour, Shahed Hammad, Randa Shahwan, Rashed Musamih, Omer Aziziye, Mohammad Zaita, Qusai Aref Fraihat, Ali Schumannalkhtib, Mohammad Al Khreisha, Hani Barakat, Mohammad Sawalmeh
    Hormone Molecular Biology and Clinical Investigation.2025;[Epub]     CrossRef
  • Imbalances in adrenal hormones and their effects on bone metabolism
    Maki Yokomoto-Umakoshi, Hironobu Umakoshi, Yoshihiro Ogawa
    Endocrine Journal.2025; 72(12): 1287.     CrossRef
  • High Risk of Fractures Within 7 Years of Diagnosis in Asian Patients With Inflammatory Bowel Diseases
    Hyung Jin Ahn, Ye-Jee Kim, Ho-Su Lee, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Beom-Jun Kim, Sang Hyoung Park
    Clinical Gastroenterology and Hepatology.2022; 20(5): e1022.     CrossRef
  • Change of Computed Tomography-Based Body Composition after Adrenalectomy in Patients with Pheochromocytoma
    Yousun Ko, Heeryoel Jeong, Seungwoo Khang, Jeongjin Lee, Kyung Won Kim, Beom-Jun Kim
    Cancers.2022; 14(8): 1967.     CrossRef
  • Bone and mineral metabolism in patients with primary aldosteronism: A systematic review and meta-analysis
    Anning Wang, Yuhan Wang, Hongzhou Liu, Xiaodong Hu, Jiefei Li, Huaijin Xu, Zhimei Nie, Lingjing Zhang, Zhaohui Lyu
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • The Entity of Connshing Syndrome: Primary Aldosteronism with Autonomous Cortisol Secretion
    Mara Carsote
    Diagnostics.2022; 12(11): 2772.     CrossRef
  • Elemental profiling of adrenal adenomas in solid tissue and blood samples by ICP-MS and ICP-OES
    Jovana Jagodić, Branislav Rovčanin, Đurđa Krstić, Ivan Paunović, Vladan Živaljević, Dragan Manojlović, Aleksandar Stojsavljević
    Microchemical Journal.2021; 165: 106194.     CrossRef
  • Aldosterone Inhibits In Vitro Myogenesis by Increasing Intracellular Oxidative Stress via Mineralocorticoid Receptor
    Jin Young Lee, Da Ae Kim, Eunah Choi, Yun Sun Lee, So Jeong Park, Beom-Jun Kim
    Endocrinology and Metabolism.2021; 36(4): 865.     CrossRef
  • Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service
    Jung Hee Kim, Hyemi Moon, Junghyun Noh, Juneyoung Lee, Sin Gon Kim
    Endocrinology and Metabolism.2020; 35(1): 157.     CrossRef
  • Pheochromocytoma and paraganglioma: An emerging cause of secondary osteoporosis
    Maki Yokomoto-Umakoshi, Hironobu Umakoshi, Tazuru Fukumoto, Yayoi Matsuda, Hiromi Nagata, Masatoshi Ogata, Hisaya Kawate, Takashi Miyazawa, Ryuichi Sakamoto, Yoshihiro Ogawa
    Bone.2020; 133: 115221.     CrossRef
  • Spironolactone reduces biochemical markers of bone turnover in postmenopausal women with primary aldosteronism
    Christian Adolf, Leah T. Braun, Carmina T. Fuss, Stefanie Hahner, Heike Künzel, Laura Handgriff, Lisa Sturm, Daniel A. Heinrich, Holger Schneider, Martin Bidlingmaier, Martin Reincke
    Endocrine.2020; 69(3): 625.     CrossRef
  • Primary Aldosteronism and Bone Metabolism: A Systematic Review and Meta-Analysis
    Shaomin Shi, Chunyan Lu, Haoming Tian, Yan Ren, Tao Chen
    Frontiers in Endocrinology.2020;[Epub]     CrossRef
  • Understanding and managing secondary osteoporosis
    Luciano Colangelo, Federica Biamonte, Jessica Pepe, Cristiana Cipriani, Salvatore Minisola
    Expert Review of Endocrinology & Metabolism.2019; 14(2): 111.     CrossRef
  • Evaluation of bone health in patients with adrenal tumors
    Shobana Athimulam, Irina Bancos
    Current Opinion in Endocrinology, Diabetes & Obesity.2019; 26(3): 125.     CrossRef
Close layer
Review Article
Update on Modern Management of Pheochromocytoma and Paraganglioma
Jacques W. M. Lenders, Graeme Eisenhofer
Endocrinol Metab. 2017;32(2):152-161.   Published online June 23, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.2.152
  • 17,632 View
  • 431 Download
  • 108 Web of Science
  • 118 Crossref
AbstractAbstract PDFPubReader   ePub   

Despite all technical progress in modern diagnostic methods and treatment modalities of pheochromocytoma/paraganglioma, early consideration of the presence of these tumors remains the pivotal link towards the best possible outcome for patients. A timely diagnosis and proper treatment can prevent the wide variety of potentially catastrophic cardiovascular complications. Modern biochemical testing should include tests that offer the best available diagnostic performance, measurements of metanephrines and 3-methoxytyramine in plasma or urine. To minimize false-positive test results particular attention should be paid to pre-analytical sampling conditions. In addition to anatomical imaging by computed tomography (CT) or magnetic resonance imaging, new promising functional imaging modalities of photon emission tomography/CT using with somatostatin analogues such as 68Ga-DOTATATE (68Ga-labeled DOTA(0)-Tyr(3)-octreotide) will probably replace 123I-MIBG (iodine-123-metaiodobenzylguanidine) in the near future. As nearly half of all pheochromocytoma patients harbor a mutation in one of the 14 tumor susceptibility genes, genetic testing and counseling should at least be considered in all patients with a proven tumor. Post-surgical annual follow-up of patients by measurements of plasma or urinary metanephrines should last for at least 10 years for timely detection of recurrent or metastatic disease. Patients with a high risk for recurrence or metastatic disease (paraganglioma, young age, multiple or large tumors, genetic background) should be followed up lifelong.

Citations

Citations to this article as recorded by  
  • Radiation Therapy for Benign Diseases and Premalignant Conditions
    Tony Y. Eng, Houda Bahig, Tiffany W. Chen, Karthik P. Meiyappan, David Roberge
    Seminars in Radiation Oncology.2026; 36: 95.     CrossRef
  • Paediatric Paraganglioma with Variant of Unknown Significance on Genetic Testing
    Jia Ling Ong, Diluka Pinto, Reshma Rajeev, Rajeev Parameswaran
    Case Reports in Oncology.2025; 18(1): 255.     CrossRef
  • Perioperative Management Challenges in Silent Pheochromocytoma: A Case Report and Literature Review
    Kai Lin, Xuan Li, Tian Guo, Haixing Zhong
    Clinical Case Reports.2025;[Epub]     CrossRef
  • Robotic Approach to Surgery for Pheochromocytoma in Children: A Case Series
    Chinny Catherine, Ashitosh Pokharkar, Deepak K. Kandpal, Priyank Yadav, Aditya Musham, Sujit K. Chowdhary
    Journal of Endourology.2025; 39(6): 556.     CrossRef
  • Catecholamine-Induced Myocarditis in Undetected Pheochromocytoma
    Narmeen Hassan, Jing W Goh , Usman Hassan
    Cureus.2025;[Epub]     CrossRef
  • Global epidemiology of pheochromocytoma: a systematic review and meta-analysis of observational studies
    Giacomo Vitturi, Salvatore Crisafulli, Ylenia Alessi, Sara Frontalini, Marilisa Giustina Stano, Andrea Fontana, Giuseppe Giuffrida, Francesco Ferraù, Gianluca Trifirò, Salvatore Cannavò
    Journal of Endocrinological Investigation.2025; 48(12): 2813.     CrossRef
  • Adrenal Incidentaloma: From Silent Diagnosis to Clinical Challenge
    Alexandra Mirica, Dana-Mihaela Tilici, Diana Loreta Paun, Ana Maria Arnautu, Victor Nimigean, Sorin Paun
    Biomedicines.2025; 13(9): 2298.     CrossRef
  • Transcriptome changes and deregulated biological pathways associated with NF1-mutated pheochromocytoma
    Anastasiya Snezhkina, Anastasiya Kobelyatskaya, Maria Fedorova, Dmitry Kalinin, Vladislav Pavlov, Anna Kudryavtseva
    Archive of Oncology.2025; 31(2): 9.     CrossRef
  • A Case of Extensive Thromboembolism as a First Presentation of a Pheochromocytoma: Pathophysiologic Insights and Strategic Surgical Intervention
    Dinesh Nirmal, Shalini Aurora, Hussam Alkaissi, Ugonna Nanna, Maria Fonseca-Mora, Lina Soni, Samy I. McFarlane
    Cureus.2025;[Epub]     CrossRef
  • Re: Alessandro Parente, Kevin Verhoeff, Yanbo Wang, et al. Robotic and Laparoscopic Adrenalectomy for Pheochromocytoma: An International Multicenter Study: Considerations for Further Research. Eur Urol Focus 2025;11:118–25
    Ciro Piccolo, Alessandro Larcher, Francesco Cei, Umberto Capitanio, Francesco Montorsi
    European Urology Focus.2025;[Epub]     CrossRef
  • Silent Pheochromocytoma Is an Underrecognized Clinical Entity: Results From a High-Volume Adrenal Surgery Hospital
    Meredith LaRue, Constantine A. Stratakis, Alejandra Kalik, Fabio R. Faucz, Tobias Carling
    Endocrine Practice.2025;[Epub]     CrossRef
  • Three-dimensional CT cinematic rendering of adrenal masses: Role in tumor analysis and management
    Taha M. Ahmed, Steven P. Rowe, Elliot K. Fishman, Philippe Soyer, Linda C. Chu
    Diagnostic and Interventional Imaging.2024; 105(1): 5.     CrossRef
  • Bone metastasis manifested 52 years after resection of an apparently benign paraganglioma: A case report
    Run Yu, Martin S Auerbach, Nathan S Honda
    SAGE Open Medical Case Reports.2024;[Epub]     CrossRef
  • A case report on pheochromocytoma mimicking as fulminant myocarditis—a diagnostic challenge
    Yanwei Cheng, Ning Ding, Longan Wang, Lijie Qin
    Frontiers in Cardiovascular Medicine.2024;[Epub]     CrossRef
  • A Case of Pheochromocytoma With Coagulation Necrosis Due to Hypertensive Crisis Aggravated by Contrast-Enhanced CT Scan and Negative 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy
    Ai Kobayashi, Yuki Ishinoda, Asuka Uto, Sho Ogata, Naoki Oshima
    Cureus.2024;[Epub]     CrossRef
  • Management of Pheochromocytomas and Paragangliomas
    Jesse E. Passman, Heather Wachtel
    Surgical Clinics of North America.2024; 104(4): 863.     CrossRef
  • Management of Abdominal Paraganglioma: A Single Center’s Experience
    Enrico Battistella, Luca Pomba, Marica Mirabella, Riccardo Toniato, Giuseppe Opocher, Antonio Toniato
    Medicina.2024; 60(4): 604.     CrossRef
  • Head and Neck Paragangliomas: Overview of Institutional Experience
    Swar N. Vimawala, Alex Z. Graboyes, Bonita Bennett, Maria Bonanni, Aleena Abbasi, Tanaya Oliphant, Michelle Alonso-Basanta, Christopher Rassekh, Debbie Cohen, Jason A. Brant, Yonghong Huan
    Cancers.2024; 16(8): 1523.     CrossRef
  • Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
    Hiroshi Mori, Hiroshi Wakabayashi, Shintaro Saito, Kenichi Nakajima, Kotaro Yoshida, Tomo Hiromasa, Seigo Kinuya
    Scientific Reports.2024;[Epub]     CrossRef
  • Inferior Laryngeal Nerve Paraganglioma With Norepinephrine Hypersecretion Diagnosed Shortly After Pregnancy
    David Kishlyansky, Rithvika Ramesh, Olivia Cook, Meera Luthra
    JCEM Case Reports.2024;[Epub]     CrossRef
  • Metabolomics and proteomics in pheochromocytoma and paraganglioma: Translating biochemistry and biology to bedside
    Jiri Petrak, Sergei G. Tevosian, Susan Richter, Hans K. Ghayee
    Best Practice & Research Clinical Endocrinology & Metabolism.2024; 38(6): 101935.     CrossRef
  • Atypical Presentation of Pheochromocytoma: A Case Report of Ventricular Tachycardia in a Young Woman
    Gurjot Singh, Kanishka Goswami, Kanwarpreet S Sandhu, Anupam Singh, Shubam Trehan, Didar Singh
    Cureus.2024;[Epub]     CrossRef
  • Perioperative Blood Pressure Management Recommendations in Pediatric Pheochromocytoma: A 10-Year Narrative Review
    Cahyani Gita Ambarsari, Nadhifah Nadhifah, Hertanti Indah Lestari
    Kidney and Blood Pressure Research.2024; 50(1): 61.     CrossRef
  • A dosimetric comparison of proton versus photon irradiation for paediatric glomus tumour: a case study
    Gabriel S. Vidal, Julie Arntzen, Salahuddin Ahmad, Christina Henson
    Journal of Radiotherapy in Practice.2023;[Epub]     CrossRef
  • Clinical presentation and diagnostic evaluation of pheochromocytoma: case series and literature review
    Panagiota Anyfanti, Κonstantinos Mastrogiannis, Αntonios Lazaridis, Κonstantinos Tasios, Despoina Vasilakou, Αnastasia Kyriazidou, Fotios Aroutsidis, Olga Pavlidou, Εleni Papoutsopoulou, Athina Tiritidou, Vasileios Kotsis, Αreti Triantafyllou, Ιoannis Zar
    Clinical and Experimental Hypertension.2023;[Epub]     CrossRef
  • Case Report: Octreotide plus CVD chemotherapy for the treatment of multiple metastatic paragangliomas after double resection for functional bladder paraganglioma and urothelial papilloma
    Zilong Wang, Feifan Liu, Chao Li, Huisheng Yuan, Yuzhu Xiang, Chunxiao Wei, Dongyuan Zhu, Muwen Wang
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Response to Peptide Receptor Radionuclide Therapy in Pheocromocytomas and Paragangliomas: A Systematic Review and Meta-Analysis
    Antonella Lucia Marretta, Alessandro Ottaiano, Domenico Iervolino, Alessandra Bracigliano, Ottavia Clemente, Francesca Di Gennaro, Roberto Tafuto, Mariachiara Santorsola, Secondo Lastoria, Salvatore Tafuto
    Journal of Clinical Medicine.2023; 12(4): 1494.     CrossRef
  • Establishment of reference intervals for plasma metanephrines in seated position measured by LC-MS/MS and assessment of diagnostic performance in pheochromocytoma/paraganglioma
    Yuxin Lin, Meihua Wang, Yingping Cao
    Annals of Clinical Biochemistry: International Journal of Laboratory Medicine.2023; 60(3): 160.     CrossRef
  • Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options
    Michal Eid, Jakub Foukal, Dana Sochorová, Štěpán Tuček, Karel Starý, Zdeněk Kala, Jiří Mayer, Radim Němeček, Jan Trna, Lumír Kunovský
    Cancer Medicine.2023; 12(13): 13942.     CrossRef
  • Editorial: Predictive tools in pheochromocytoma and paraganglioma
    Filippo Ceccato, Ricardo Correa, Masha Livhits, Henrik Falhammar
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Functional retroperitoneal paraganglioma invading the inferior vena cava in the elderly, a case report and literature review
    Mohamed Aymane Loukili, Imane Assarrar, Nada El Yamani, Anass Haloui, Siham Rouf, Hanane Latrech
    International Journal of Surgery Case Reports.2023; 109: 108547.     CrossRef
  • Pediatric total fractionated metanephrines: age-related reference intervals in spot urine
    Laura ROLI, Agnese VERONESI, Maria C. DE SANTIS, Enrica BARALDI
    Minerva Pediatrics.2023;[Epub]     CrossRef
  • An Overview of Circulating Biomarkers in Neuroendocrine Neoplasms: A Clinical Guide
    Michele Bevere, Francesca Masetto, Maria Elena Carazzolo, Alice Bettega, Anastasios Gkountakos, Aldo Scarpa, Michele Simbolo
    Diagnostics.2023; 13(17): 2820.     CrossRef
  • Pheochromocytoma: a changing perspective and current concepts
    Andreas Kiriakopoulos, Periklis Giannakis, Evangelos Menenakos
    Therapeutic Advances in Endocrinology and Metabolism.2023;[Epub]     CrossRef
  • N-doped carbon Co/CoOx with laccase-like activity for detection of epinephrine
    Junlun Zhu, Qian Cui, Tao Long, Yijia Wang, Wei Wen, Zhengfang Tian, Xiuhua Zhang, Shengfu Wang
    Microchimica Acta.2023;[Epub]     CrossRef
  • Targeted radionuclide therapy in endocrine-related cancers: advances in the last decade
    Taymeyah Al-Toubah, Jonathan Strosberg, Julie Hallanger-Johnson, Ghassan El-Haddad
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • An Atypical Presentation of Childhood Paraganglioma with Seizures: A Case Report and Review of the Literature
    Elizabeth Eberechi Oyenusi, Uzoamaka Felicia Nwigbo, Oluwadamilola Moromoke Oladipo, Blessing Ebele Kene-Udemezue, Kasarachi Pauline Akowundu, Khadijah Omobusola Oleolo-Ayodeji, Oluwaseun Adunni Afoke, Funmilayo Oluwatoyin Babatunde, Felix Makinde Alakalo
    Case Reports in Endocrinology.2023; 2023: 1.     CrossRef
  • Comparison of the effectiveness of various methods for determining the level of metanephrines in the diagnosis of pheochromocytomas
    Sh. Sh. Shikhmagomedov, D. V. Rebrova, L. M. Krasnov, E. A. Fedorov, I. K. Chinchuk, R. A. Chernikov, V. F. Rusakov, I. V. Slepstov, E. A. Zgoda
    Problems of Endocrinology.2023; 70(2): 46.     CrossRef
  • Addition of 3‐methoxytyramine or chromogranin A to plasma free metanephrines as the initial test for pheochromocytoma and paraganglioma: Which is the best diagnostic strategy
    Lu Liu, Wenchun Xie, Zhijing Song, Tianyu Wang, Xuesong Li, Ying Gao, Yan Li, Junqing Zhang, Xiaohui Guo
    Clinical Endocrinology.2022; 96(2): 132.     CrossRef
  • Hereditary and Sporadic Pheochromocytoma: Comparison of Imaging, Clinical, and Laboratory Features
    Ryan Chung, Aileen O'Shea, Ann T. Sweeney, Nathaniel D. Mercaldo, Shaunagh McDermott, Michael A. Blake
    American Journal of Roentgenology.2022; 219(1): 97.     CrossRef
  • Nonvestibular Schwannomas of the Head and Neck
    A.H. Duran, M.T. Starc, A. Khorsandi
    Neurographics.2022; 12(1): 25.     CrossRef
  • Preoperative Alpha-Blocker Therapy in Patients with Missed Preoperative Diagnosis of Extra-Adrenal Retroperitoneal Paraganglioma Undergoing Resection: A Retrospective Study of 167 Cases at a Single Center
    Yi Liu, Xinye Jin, Jie Gao, Shan Jiang, Lei Liu, Jingsheng Lou, Bo Wang, Hong Zhang, Qiang Fu
    Neuroendocrinology.2022; 112(5): 457.     CrossRef
  • Metastatic pheochromocytomas and paragangliomas: where are we?
    Natalie Prinzi, Francesca Corti, Martina Torchio, Monica Niger, Maria Antista, Filippo Pagani, Teresa Beninato, Iolanda Pulice, Roberta Elisa Rossi, Jorgelina Coppa, Tommaso Cascella, Luca Giacomelli, Maria Di Bartolomeo, Massimo Milione, Filippo de Braud
    Tumori Journal.2022; 108(6): 526.     CrossRef
  • Feocromocitoma adrenal. Claves para el diagnóstico radiológico
    M.A. Corral de la Calle, J. Encinas de la Iglesia, G.C. Fernández-Pérez, M. Repollés Cobaleda, A. Fraino
    Radiología.2022; 64(4): 348.     CrossRef
  • Is the Adrenal Incidentaloma Functionally Active? An Approach-To-The-Patient-Based Review
    Stella Bernardi, Veronica Calabrò, Marco Cavallaro, Sara Lovriha, Rita Eramo, Bruno Fabris, Nicolò de Manzini, Chiara Dobrinja
    Journal of Clinical Medicine.2022; 11(14): 4064.     CrossRef
  • Systematic Review: Incidence of Pheochromocytoma and Paraganglioma Over 70 Years
    Abdul Rahman Al Subhi, Veronica Boyle, Marianne S Elston
    Journal of the Endocrine Society.2022;[Epub]     CrossRef
  • Management of Patients with Treatment of Pheochromocytoma: A Critical Appraisal
    Florence Bihain, Claire Nomine-Criqui, Philippe Guerci, Stephane Gasman, Marc Klein, Laurent Brunaud
    Cancers.2022; 14(16): 3845.     CrossRef
  • Adrenal pheochromocytoma: Keys to radiologic diagnosis
    M.A. Corral de la Calle, J. Encinas de la Iglesia, G.C. Fernández-Pérez, M. Repollés Cobaleda, A. Fraino
    Radiología (English Edition).2022; 64(4): 348.     CrossRef
  • Preoperative blood pressure targets and effect on hemodynamics in pheochromocytoma and paraganglioma
    Randi Ugleholdt, Åse Krogh Rasmussen, Pernille A H Haderslev, Bjarne Kromann-Andersen, Claus Larsen Feltoft
    Endocrine Connections.2022;[Epub]     CrossRef
  • Liquid chromatography–tandem mass spectrometry for clinical diagnostics
    Stefani N. Thomas, Deborah French, Paul J. Jannetto, Brian A. Rappold, William A. Clarke
    Nature Reviews Methods Primers.2022;[Epub]     CrossRef
  • Acute Stress Cardiomyopathy: Heart of pheochromocytoma
    Erika Cornu, Justina Motiejunaite, Ines Belmihoub, Emmanuelle Vidal-Petiot, Mariana Mirabel, Laurence Amar
    Annales d'Endocrinologie.2021; 82(3-4): 201.     CrossRef
  • Endocrine causes of heart failure: A clinical primer for cardiologists
    Saurav Khatiwada, Hiya Boro, Faraz Ahmed Farooqui, Sarah Alam
    Indian Heart Journal.2021; 73(1): 14.     CrossRef
  • Recurrence Rate of Sporadic Pheochromocytomas After Curative Adrenalectomy: A Systematic Review and Meta-analysis
    Isabelle Holscher, Tijs J van den Berg, Koen M A Dreijerink, Anton F Engelsman, Els J M Nieveen van Dijkum
    The Journal of Clinical Endocrinology & Metabolism.2021; 106(2): 588.     CrossRef
  • Overview of Monogenic Forms of Hypertension Combined With Hypokalemia
    Yi-Ting Lu, Peng Fan, Di Zhang, Ying Zhang, Xu Meng, Qiong-Yu Zhang, Lin Zhao, Kun-Qi Yang, Xian-Liang Zhou
    Frontiers in Pediatrics.2021;[Epub]     CrossRef
  • Management of the patient with incidental bilateral adrenal nodules
    Ann T. Sweeney, Padmavathi Srivoleti, Michael A. Blake
    Journal of Clinical and Translational Endocrinology: Case Reports.2021; 20: 100082.     CrossRef
  • Arterial thrombosis and intracardiac thrombus as the initial presentation of a recurrent paraganglioma: case report and review of the literature
    Dania Lizet Quintanilla-Flores, Jesús Zacarías Villarreal-Pérez, Claudia Analy Vélez-Viveros, Paola Portillo-Sánchez, Adriana Josefina Ortíz-Morales, José Gerardo González-González
    Archives of Endocrinology and Metabolism.2021;[Epub]     CrossRef
  • La gestione perioperatoria delle masse surrenaliche
    Filippo Ceccato, Carla Scaroni
    L'Endocrinologo.2021; 22(2): 127.     CrossRef
  • Verifying Clinically Derived Reference Intervals for Daily Excretion Rates of Fractionated Metanephrines Using Modern Indirect Reference Interval Models
    Kelly Doyle, Elizabeth L Frank
    American Journal of Clinical Pathology.2021; 156(4): 691.     CrossRef
  • Identification of vital prognostic genes related to tumor microenvironment in pheochromocytoma and paraganglioma based on weighted gene co-expression network analysis
    Chun-Xian Chen, Dong-Ning Chen, Xiong-Lin Sun, Zhi-Bin Ke, Fei Lin, Hang Chen, Xuan Tao, Fei Huang, Yong Wei, Ning Xu
    Aging.2021; 13(7): 9976.     CrossRef
  • Pheochromocytoma in a 49-year-old woman presenting with acute myocardial infarction: A case report
    Hao-Yu Wu, Yi-Wei Cao, Tian-Jiao Gao, Jian-Li Fu, Lei Liang
    World Journal of Clinical Cases.2021; 9(15): 3752.     CrossRef
  • Mutation Profile of Aggressive Pheochromocytoma and Paraganglioma with Comparison of TCGA Data
    Yun Mi Choi, Jinyeong Lim, Min Ji Jeon, Yu-Mi Lee, Tae-Yon Sung, Eun-Gyoung Hong, Ji-Young Lee, Se Jin Jang, Won Gu Kim, Dong Eun Song, Sung-Min Chun
    Cancers.2021; 13(10): 2389.     CrossRef
  • Hypertension in Pheochromocytoma and Paraganglioma: Evaluation and Management in Pediatric Patients
    Meredith L. Seamon, Ikuyo Yamaguchi
    Current Hypertension Reports.2021;[Epub]     CrossRef
  • Endocrine hypertension secondary to adrenal tumors: clinical course and predictive factors of clinical remission
    Uriel Clemente-Gutiérrez, Rafael H. Pérez-Soto, Juan D. Hernández-Acevedo, Nicole M. Iñiguez-Ariza, Enrique Casanueva-Pérez, Juan Pablo Pantoja-Millán, Mauricio Sierra-Salazar, Miguel F. Herrera, David Velázquez-Fernández
    Langenbeck's Archives of Surgery.2021; 406(6): 2027.     CrossRef
  • A multidisciplinary approach to the management of adrenal incidentaloma
    Giacomo Voltan, Marco Boscaro, Decio Armanini, Carla Scaroni, Filippo Ceccato
    Expert Review of Endocrinology & Metabolism.2021; 16(4): 201.     CrossRef
  • Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
    Manisha H. Shah, Whitney S. Goldner, Al B. Benson, Emily Bergsland, Lawrence S. Blaszkowsky, Pamela Brock, Jennifer Chan, Satya Das, Paxton V. Dickson, Paul Fanta, Thomas Giordano, Thorvardur R. Halfdanarson, Daniel Halperin, Jin He, Anthony Heaney, Marti
    Journal of the National Comprehensive Cancer Network.2021; 19(7): 839.     CrossRef
  • Plasma Metabolome Profiling for the Diagnosis of Catecholamine Producing Tumors
    Juliane März, Max Kurlbaum, Oisin Roche-Lancaster, Timo Deutschbein, Mirko Peitzsch, Cornelia Prehn, Dirk Weismann, Mercedes Robledo, Jerzy Adamski, Martin Fassnacht, Meik Kunz, Matthias Kroiss
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Bilateral carotid paraganglioma: A case report
    Jean Michel Nzisabira, Eugène Ndirahisha, Sébastien Manirakiza, Linda Samantha Nzisabira, Patrice Barasukana, Léopold Nzisabira
    International Journal of Case Reports and Images.2021; 12: 1.     CrossRef
  • An Overview on Pheochromocytoma Diagnosis and Management Approach, Review Article
    Yazeed Ali Aljabri, Faris Sami Alghamdi, Khaled Ahmed Almehmadi, Abdulrahman Abubaker Babkoor, Abdulhafiz Muhammad Bahalaq, Anwar Aziz Althaqfi, Abdullah Ghazi Alharbi, Rayan Saud Alhazmi, Ahmad Ali Almalki
    World Journal of Environmental Biosciences.2021; 10(3): 18.     CrossRef
  • Bladder paraganglioma: CT and MR imaging characteristics in 16 patients
    Jing Zhang, Xu Bai, Jing Yuan, Xiaojing Zhang, Wei Xu, Huiyi Ye, Haiyi Wang
    Radiology and Oncology.2021; 56(1): 46.     CrossRef
  • Laparoscopic Partial Resection of Retroperitoneal Extramedullary Plasmacytoma
    Andrzej Gasz, Jan Danko, Maros Straka, Lazo Ilic, José M. Ramia
    Cirugía Española (English Edition).2020; 98(5): 299.     CrossRef
  • Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service
    Jung Hee Kim, Hyemi Moon, Junghyun Noh, Juneyoung Lee, Sin Gon Kim
    Endocrinology and Metabolism.2020; 35(1): 157.     CrossRef
  • Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy
    Mirko Parasiliti-Caprino, Barbara Lucatello, Chiara Lopez, Jacopo Burrello, Francesca Maletta, Marinella Mistrangelo, Enrica Migliore, Francesco Tassone, Antonio La Grotta, Anna Pia, Giuseppe Reimondo, Roberta Giordano, Giuseppe Giraudo, Alessandro Pioves
    Hypertension Research.2020; 43(6): 500.     CrossRef
  • A Brief Overview of the Epidemiology of Pheochromocytoma and Paraganglioma in Korea
    Yun Mi Choi
    Endocrinology and Metabolism.2020; 35(1): 95.     CrossRef
  • Pheochromocytoma and paraganglioma—an update on diagnosis, evaluation, and management
    Amrish Jain, Rossana Baracco, Gaurav Kapur
    Pediatric Nephrology.2020; 35(4): 581.     CrossRef
  • Short-term stability of free metanephrines in plasma and whole blood
    Elisa Danese, Martina Montagnana, Claudio Brentegani, Giuseppe Lippi
    Clinical Chemistry and Laboratory Medicine (CCLM).2020; 58(5): 753.     CrossRef
  • Meta-analysis of α-blockade versus no blockade before adrenalectomy for phaeochromocytoma
    S Schimmack, J Kaiser, P Probst, E Kalkum, M K Diener, O Strobel
    British Journal of Surgery.2020; 107(2): e102.     CrossRef
  • In Matrix Derivatization Combined with LC-MS/MS Results in Ultrasensitive Quantification of Plasma Free Metanephrines and Catecholamines
    Martijn van Faassen, Rainer Bischoff, Karin Eijkelenkamp, Wilhelmina H. A. de Jong, Claude P. van der Ley, Ido P. Kema
    Analytical Chemistry.2020; 92(13): 9072.     CrossRef
  • Resección parcial laparoscópica de plasmocitoma extramedular retroperitoneal
    Andrzej Gasz, Jan Danko, Maros Straka, Lazo Ilic, José M. Ramia
    Cirugía Española.2020; 98(5): 299.     CrossRef
  • Bladder Preservation for Patients With Bladder Paragangliomas: Case Series and Review of the Literature
    Elizabeth Y. Wang, Jamie S. Pak, Renu K. Virk, Christopher B. Anderson, Kelly A. Healy, James A. Lee, Mitchell C. Benson, James M. McKiernan
    Urology.2020; 143: 194.     CrossRef
  • Decision-Making in Artificial Intelligence: Is It Always Correct?
    Hun-Sung Kim
    Journal of Korean Medical Science.2020;[Epub]     CrossRef
  • Pheochromocytoma and Paraganglioma
    James K. Moon, Peter Mattei
    Seminars in Pediatric Surgery.2020; 29(3): 150926.     CrossRef
  • 52-Year-Old Woman With Fever, Diaphoresis, and Abdominal Pain
    Thomas J. Breen, Brenden S. Ingraham, Jacob C. Jentzer
    Mayo Clinic Proceedings.2020; 95(7): e69.     CrossRef
  • Diagnostic des phéochromocytomes et paragangliomes
    F. Castinetti, A. Barlier, F. Sebag, D. Taieb
    Oncologie.2020;[Epub]     CrossRef
  • Glucocorticoid Excess in Patients with Pheochromocytoma Compared with Paraganglioma and Other Forms of Hypertension
    Georgiana Constantinescu, Katharina Langton, Catleen Conrad, Laurence Amar, Guillaume Assié, Anne-Paule Gimenez-Roqueplo, Anne Blanchard, Casper K Larsen, Paolo Mulatero, Tracy Ann Williams, Aleksander Prejbisz, Martin Fassnacht, Stefan Bornstein, Filippo
    The Journal of Clinical Endocrinology & Metabolism.2020; 105(9): e3374.     CrossRef
  • PDK1 Inhibitor GSK-470 Exhibits Potent Anticancer Activity in a Pheochromocytoma PC12 Cell Tumor Model via Akt/mTOR Pathway
    Xiaohua Zhang, Shan Zhong
    Anti-Cancer Agents in Medicinal Chemistry.2020; 20(7): 828.     CrossRef
  • ‘Case of the month’ from UConn Health, Farmington, CT, USA: management of a giant paraganglioma
    Vikram Lyall, Michael E. Goltzman, Mina L. Boutrous, Ravali Nallu, Peter C. Albertsen, Beatriz E. Tendler, Benjamin T. Ristau
    BJU International.2020; 126(5): 551.     CrossRef
  • Perioperative management of pheocromocytoma/ paraganglioma: a comprehensive review
    Alejandro Román-González, Huber Padilla-Zambrano, Luis Felipe Vásquez Jimenez
    Colombian Journal of Anesthesiology.2020;[Epub]     CrossRef
  • Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research Approaches
    Laura Gieldon, Doreen William, Karl Hackmann, Winnie Jahn, Arne Jahn, Johannes Wagner, Andreas Rump, Nicole Bechmann, Svenja Nölting, Thomas Knösel, Volker Gudziol, Georgiana Constantinescu, Jimmy Masjkur, Felix Beuschlein, Henri JLM Timmers, Letizia Canu
    Cancers.2019; 11(6): 809.     CrossRef
  • Blood Pressure Profile, Catecholamine Phenotype, and Target Organ Damage in Pheochromocytoma/Paraganglioma
    Ondřej Petrák, Ján Rosa, Robert Holaj, Branislav Štrauch, Zuzana Krátká, Jan Kvasnička, Judita Klímová, Petr Waldauf, Barbora Hamplová, Alice Markvartová, Květoslav Novák, David Michalský, Jiří Widimský, Tomáš Zelinka
    The Journal of Clinical Endocrinology & Metabolism.2019; 104(11): 5170.     CrossRef
  • Expression of PDK1 in malignant pheochromocytoma as a new promising potential therapeutic target
    X. Zhang, Z. Yu
    Clinical and Translational Oncology.2019; 21(10): 1312.     CrossRef
  • Prospective evaluation of 68Ga-DOTANOC positron emission tomography/computed tomography and 131I-meta-iodobenzylguanidine single-photon emission computed tomography/computed tomography in extra-adrenal paragangliomas, including uncommon primary sites and
    Saurabh Arora, Rakesh Kumar, Averilicia Passah, Madhavi Tripathi, Sandeep Agarwala, Rajesh Khadgawat, Chandrasekhar Bal
    Nuclear Medicine Communications.2019; 40(12): 1230.     CrossRef
  • Combinatorial Inhibition of mTORC2 and Hsp90 Leads to a Distinctly Effective Therapeutic Strategy in Malignant Pheochromocytoma
    Xiaohua Zhang, Fengbin Gao, Shan Zhong
    Current Cancer Drug Targets.2019; 19(9): 698.     CrossRef
  • Ischémie aiguë du membre inférieur et acidocétose diabétique révélant un phéochromocytome
    Kamal Ahsayan, Amine Ghalem, Mohammed Bouziane, Noha El Ouafi, Brahim Housni
    Anesthésie & Réanimation.2019; 5(4): 337.     CrossRef
  • Enfoque diagnóstico de feocromocitomas y paragangliomas
    R.M. Gómez, M. Hernaiz, V. de Miguel, L.S. Aparicio, M.J. Marín, S. Lupi, M. Barontini
    Hipertensión y Riesgo Vascular.2019; 36(1): 34.     CrossRef
  • Phéochromocytome et paragangliome
    E. Cornu, I. Belmihoub, N. Burnichon, C. Grataloup, F. Zinzindohoué, S. Baron, E. Billaud, M. Azizi, A.-P. Gimenez-Roqueplo, L. Amar
    La Revue de Médecine Interne.2019; 40(11): 733.     CrossRef
  • Rendimiento de las metanefrinas libres plasmáticas en el diagnóstico de los feocromocitomas y paragangliomas en la población asturiana
    Eduardo Martínez-Morillo, Nuria Valdés Gallego, Edwin Eguia Ángeles, Juan Carlos Fernández Fernández, Belén Prieto García, Francisco V. Álvarez
    Endocrinología, Diabetes y Nutrición.2019; 66(5): 312.     CrossRef
  • The Identification of Differentially Expressed Genes Showing Aberrant Methylation Patterns in Pheochromocytoma by Integrated Bioinformatics Analysis
    Dengqiang Lin, Jinglai Lin, Xiaoxia Li, Jianping Zhang, Peng Lai, Zhifeng Mao, Li Zhang, Yu Zhu, Yujun Liu
    Frontiers in Genetics.2019;[Epub]     CrossRef
  • Pharmacological and analytical interference in hormone assays for diagnosis of adrenal incidentaloma
    Antoine-Guy Lopez, François Fraissinet, Herve Lefebvre, Valéry Brunel, Frédéric Ziegler
    Annales d'Endocrinologie.2019; 80(4): 250.     CrossRef
  • Analysis of Short-term Blood Pressure Variability in Pheochromocytoma/Paraganglioma Patients
    Valeria Bisogni, Luigi Petramala, Gaia Oliviero, Maria Bonvicini, Martina Mezzadri, Federica Olmati, Antonio Concistrè, Vincenza Saracino, Monia Celi, Gianfranco Tonnarini, Gino Iannucci, Giorgio De Toma, Antonio Ciardi, Giuseppe La Torre, Claudio Letizia
    Cancers.2019; 11(5): 658.     CrossRef
  • Imaging Features of Succinate Dehydrogenase–deficient Pheochromocytoma-Paraganglioma Syndromes
    Samuel Joseph Withey, Stephen Perrio, Dimitra Christodoulou, Louise Izatt, Paul Carroll, Anand Velusamy, Rupert Obholzer, Valerie Lewington, Audrey Eleanor Therese Jacques
    RadioGraphics.2019; 39(5): 1393.     CrossRef
  • A Clinical Efficacy of PRRT in Patients with Advanced, Nonresectable, Paraganglioma-Pheochromocytoma, Related to SDHx Gene Mutation
    Agnieszka Kolasinska-Ćwikła, Mariola Pęczkowska, Jarosław Ćwikła, Ilona Michałowska, Jakub Pałucki, Lisa Bodei, Anna Lewczuk-Myślicka, Andrzej Januszewicz
    Journal of Clinical Medicine.2019; 8(7): 952.     CrossRef
  • A Branching Algorithm
    Elisabeth Pedersen, Gurpreet Dhaliwal, Ashwin Gupta, Tobias Else, Robert Chang, Nathan Houchens
    Journal of Hospital Medicine.2019; 14(11): 707.     CrossRef
  • Liquid chromatography tandem mass spectrometry for plasma metadrenalines
    S.L. Davies, A.S. Davison
    Clinica Chimica Acta.2019; 495: 512.     CrossRef
  • Addressing delays in the diagnosis of pheochromocytoma/paraganglioma
    Ioannis Ilias, Costas Thomopoulos
    Expert Review of Endocrinology & Metabolism.2019; 14(5): 359.     CrossRef
  • Performance of plasma free metanephrines in diagnosis of pheochromocytomas and paragangliomas in the population of Asturias
    Eduardo Martínez-Morillo, Nuria Valdés Gallego, Edwin Eguia Ángeles, Juan Carlos Fernández Fernández, Belén Prieto García, Francisco V. Álvarez
    Endocrinología, Diabetes y Nutrición (English ed.).2019; 66(5): 312.     CrossRef
  • A Case of Sudden Death: Subarachnoid Hemorrhage, Pheochromocytoma, Berry Aneurysm
    Ana B. Arevalo, Jacxelyn Moran, Stephen Zink, Binny Khandakar
    Case Reports in Pathology.2019; 2019: 1.     CrossRef
  • Pheochromocytoma
    Frederick-Anthony Farrugia, Anestis Charalampopoulos
    Endocrine Regulations.2019; 53(3): 191.     CrossRef
  • What's New in Endocrinology: The Chromaffin Cell
    Lee E. Eiden, Sunny Zhihong Jiang
    Frontiers in Endocrinology.2018;[Epub]     CrossRef
  • Pheochromocytoma: A Genetic And Diagnostic Update
    Leilani B. Mercado-Asis, Katherine I. Wolf, Ivana Jochmanova, David Taïeb
    Endocrine Practice.2018; 24(1): 78.     CrossRef
  • Retroperitoneal Paraganglioma Involving the Renal Hilum: A Case Report and Literature Review
    Peter Yincheng Cai, Ron Golan, Brent Yanke
    Urology.2018; 122: 24.     CrossRef
  • Fluorescent ternary complexes of some biogenic amines and their metabolites with europium and oxytetracycline for applications in the chemical analysis
    Maria I. Makedonskaya, Anastasiya M. Mikhailova, Irina A. Veselova, Junji Fukuda, Tatyana N. Shekhovtsova
    Mendeleev Communications.2018; 28(5): 553.     CrossRef
  • Phéochromocytomes et paragangliomes génétiquement déterminés: quelle conduite à tenir chez les apparentés ?
    Marie Vermalle, Antoine Tabarin, Frederic Castinetti
    Annales d'Endocrinologie.2018; 79: S10.     CrossRef
  • Exosomal double-stranded DNA as a biomarker for the diagnosis and preoperative assessment of pheochromocytoma and paraganglioma
    Liang Wang, Ying Li, Xin Guan, Jingyuan Zhao, Liming Shen, Jing Liu
    Molecular Cancer.2018;[Epub]     CrossRef
  • Strain-specific metastatic phenotypes in pheochromocytoma allograft mice
    Martin Ullrich, Josephine Liers, Mirko Peitzsch, Anja Feldmann, Ralf Bergmann, Ulrich Sommer, Susan Richter, Stefan R Bornstein, Michael Bachmann, Graeme Eisenhofer, Christian G Ziegler, Jens Pietzsch
    Endocrine-Related Cancer.2018; 25(12): 993.     CrossRef
  • Secondary Arterial Hypertension: From Routine Clinical Practice to Evidence in Patients with Adrenal Tumor
    Marco Grasso, Marco Boscaro, Carla Scaroni, Filippo Ceccato
    High Blood Pressure & Cardiovascular Prevention.2018; 25(4): 345.     CrossRef
  • Amperometric Determination of Catecholamines by Enzymatic Biosensors in Flow Systems
    Oksana Josypčuk, Jiří Barek, Bohdan Josypčuk
    Electroanalysis.2018; 30(6): 1163.     CrossRef
  • Trace Amines and Their Receptors
    Raul R. Gainetdinov, Marius C. Hoener, Mark D. Berry
    Pharmacological Reviews.2018; 70(3): 549.     CrossRef
  • Methods of Paraclinic Diagnosis of Catecholamine Secreting Tumours, Especially of Pheochromocytoma
    Florin Mitu, Alexandra Maștaleru, Clementina Cojocaru, Mihai Roca, Ovidiu Mitu, Maria-Magdalena Leon-Constantin
    Internal Medicine.2018; 15(2): 31.     CrossRef
Close layer
Original Article
Clinical Study
A 5-Year Prospective Follow-Up Study of Lipid-Rich Adrenal Incidentalomas: No Tumor Growth or Development of Hormonal Hypersecretion
Camilla Schalin-Jäntti, Merja Raade, Esa Hämäläinen, Timo Sane
Endocrinol Metab. 2015;30(4):481-487.   Published online December 31, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.4.481
  • 6,382 View
  • 49 Download
  • 24 Web of Science
  • 24 Crossref
AbstractAbstract PDFPubReader   
Background

Current guidelines for follow-up of adrenal incidentalomas are extensive and hampered by lack of follow-up studies. We tested the hypothesis that small lipid-rich adrenal incidentalomas, initially characterized by tumor size <40 mm and <10 Hounsfield units (HUs) on unenhanced computed tomography (CT) may not demonstrate excessive growth/hormonal hypersecretion on follow-up.

Methods

Sixty-nine incidentalomas in 56 patients were restudied with unenhanced CT and screening for hypercortisolism (dexamethasone suppression test [DST], plasma adrenocorticotropic hormone) and pheochromocytoma (24-hour urinary metanephrines and normetanephrines) 5 years later. Primary hyperaldosteronism was excluded at base-line.

Results

Tumor (n=69) size was similar before and after 5 years follow-up (19±6 mm vs. 20±7 mm). Mean tumor growth was 1±2 mm. Largest increase in tumor size was 8 mm, this tumor was surgically removed and histopathology confirmed cortical adenoma. DST was normal in 54 patients and two patients (3.6%) were still characterized by subclinical hypercortisolism. Initial tumor size was >20 mm for the patient with largest tumor growth and those with subclinical hypercortisolism. All patients had normal 24-hour urinary metanephrines and normetanephrines. Low attenuation (<10 HU) was demonstrated in 97% of 67 masses re-evaluated with unenhanced CT.

Conclusion

None of the patients developed clinically relevant tumor growth or new subclinical hypercortisolism. Biochemical screening for pheochromocytoma in incidentalomas demonstrating <10 HU on unenhanced CT is not needed. For such incidentalomas <40 mm, it seems sufficient to perform control CT and screen for hypercortisolism after 5 years.

Citations

Citations to this article as recorded by  
  • Clinical and Radiological Features of Atypical Adrenal Masses—A Multicenter Retrospective Study
    Vania Balderrama-Brondani, Ruaa Al-Ward, Katja Kiseljak-Vassiliades, Lauren Fishbein, Danielle Dawes, Oksana Hamidi, Reza Pishdad, Juan Pablo Perdomo Rodriguez, Mohamad Anas Sukkari, Joseph R Grajo, Hans Kumar Ghayee, Sara Bedrose, Roland L Bassett, Amir
    The Journal of Clinical Endocrinology & Metabolism.2025; 110(7): e2183.     CrossRef
  • Washed up: the end of an era for adrenal incidentaloma CT
    James H. Seow, Damien L. Stella, Christopher J. Welman, Arjuna J. Somasundaram, Jan F. Gerstenmaier
    Insights into Imaging.2025;[Epub]     CrossRef
  • European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors
    Martin Fassnacht, Stylianos Tsagarakis, Massimo Terzolo, Antoine Tabarin, Anju Sahdev, John Newell-Price, Iris Pelsma, Ljiljana Marina, Kerstin Lorenz, Irina Bancos, Wiebke Arlt, Olaf M Dekkers
    European Journal of Endocrinology.2023; 189(1): G1.     CrossRef
  • Diagnostic Accuracy of CT Texture Analysis in Adrenal Masses: A Systematic Review
    Filippo Crimì, Emilio Quaia, Giulio Cabrelle, Chiara Zanon, Alessia Pepe, Daniela Regazzo, Irene Tizianel, Carla Scaroni, Filippo Ceccato
    International Journal of Molecular Sciences.2022; 23(2): 637.     CrossRef
  • Susceptibility and characteristics of infections in patients with glucocorticoid excess or insufficiency: the ICARO tool
    Marianna Minnetti, Valeria Hasenmajer, Emilia Sbardella, Francesco Angelini, Chiara Simeoli, Nicola Di Paola, Alessia Cozzolino, Claudia Pivonello, Dario De Alcubierre, Sabrina Chiloiro, Roberto Baldelli, Laura De Marinis, Rosario Pivonello, Riccardo Pofi
    European Journal of Endocrinology.2022; 187(5): 719.     CrossRef
  • Approach to large adrenal tumors
    Urszula Ambroziak
    Current Opinion in Endocrinology, Diabetes & Obesity.2021; 28(3): 271.     CrossRef
  • Frequently asked questions and answers (if any) in patients with adrenal incidentaloma
    F. Ceccato, M. Barbot, C. Scaroni, M. Boscaro
    Journal of Endocrinological Investigation.2021; 44(12): 2749.     CrossRef
  • Draft of the clinical practice guidelines “Adrenal incidentaloma”
    D. G. Beltsevich, E. A. Troshina, G. A. Melnichenko, N. M. Platonova, D. O. Ladygina, A. Chevais
    Endocrine Surgery.2021; 15(1): 4.     CrossRef
  • Attenuation Value in Adrenal Incidentalomas: A Longitudinal Study
    Filippo Ceccato, Irene Tizianel, Giacomo Voltan, Gianmarco Maggetto, Isabella Merante Boschin, Emilio Quaia, Filippo Crimì, Carla Scaroni
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Guía práctica sobre la evaluación inicial, seguimiento y tratamiento de los incidentalomas adrenales. Grupo de patología adrenal de la Sociedad Española de Endocrinología y Nutrición
    Marta Araujo-Castro, Marta Iturregui Guevara, María Calatayud Gutiérrez, Paola Parra Ramírez, Paola Gracia Gimeno, Felicia Alexandra Hanzu, Cristina Lamas Oliveira
    Endocrinología, Diabetes y Nutrición.2020; 67(6): 408.     CrossRef
  • Practical guide on the initial evaluation, follow-up, and treatment of adrenal incidentalomas. Adrenal Diseases Group of the Spanish Society of Endocrinology and Nutrition
    Marta Araujo-Castro, Marta Iturregui Guevara, María Calatayud Gutiérrez, Paola Parra Ramírez, Paola Gracia Gimeno, Felicia Alexandra Hanzu, Cristina Lamas Oliveira
    Endocrinología, Diabetes y Nutrición (English ed.).2020; 67(6): 408.     CrossRef
  • Endocrine Causes of Hypertension
    Taniya de Silva, Gina Cosentino, Suneeta Ganji, Alejandra Riera-Gonzalez, Daniel S. Hsia
    Current Hypertension Reports.2020;[Epub]     CrossRef
  • Adrenocortical carcinoma: presentation and outcome of a contemporary patient series
    Iiro Kostiainen, Liisa Hakaste, Pekka Kejo, Helka Parviainen, Tiina Laine, Eliisa Löyttyniemi, Mirkka Pennanen, Johanna Arola, Caj Haglund, Ilkka Heiskanen, Camilla Schalin-Jäntti
    Endocrine.2019; 65(1): 166.     CrossRef
  • CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma
    Letizia Canu, Janna A W Van Hemert, Michiel N Kerstens, Robert P Hartman, Aakanksha Khanna, Ivana Kraljevic, Darko Kastelan, Corin Badiu, Urszula Ambroziak, Antoine Tabarin, Magalie Haissaguerre, Edward Buitenwerf, Anneke Visser, Massimo Mannelli, Wiebke
    The Journal of Clinical Endocrinology & Metabolism.2019; 104(2): 312.     CrossRef
  • The Evaluation of Incidentally Discovered Adrenal Masses
    Anand Vaidya, Amir Hamrahian, Irina Bancos, Maria Fleseriu, Hans K. Ghayee
    Endocrine Practice.2019; 25(2): 178.     CrossRef
  • Evaluation of quantitative parameters for distinguishing pheochromocytoma from other adrenal tumors
    Youichi Ohno, Masakatsu Sone, Daisuke Taura, Toshinari Yamasaki, Katsutoshi Kojima, Kyoko Honda-Kohmo, Yorihide Fukuda, Koji Matsuo, Toshihito Fujii, Akihiro Yasoda, Osamu Ogawa, Nobuya Inagaki
    Hypertension Research.2018; 41(3): 165.     CrossRef
  • Long term follow-up of non functional adrenal incidentalomas in size: a single center experience
    Güven Barış Cansu, Bengür Taşkıran, Eylem Bahadır
    Ortadoğu Tıp Dergisi.2018; 10(4): 506.     CrossRef
  • Unenhanced CT imaging is highly sensitive to exclude pheochromocytoma: a multicenter study
    Edward Buitenwerf, Tijmen Korteweg, Anneke Visser, Charlotte M S C Haag, Richard A Feelders, Henri J L M Timmers, Letizia Canu, Harm R Haak, Peter H L T Bisschop, Elisabeth M W Eekhoff, Eleonora P M Corssmit, Nanda C Krak, Elise Rasenberg, Janneke van den
    European Journal of Endocrinology.2018; 178(5): 431.     CrossRef
  • The impact of an adrenal incidentaloma algorithm on the evaluation of adrenal nodules
    Leslie S. Eldeiry, Marina M. Alfisher, Catherine F. Callahan, Nancy N. Hanna, Jeffrey R. Garber
    Journal of Clinical & Translational Endocrinology.2018; 13: 39.     CrossRef
  • Adrenal incidentaloma: differential diagnosis and management strategies
    Valentina Morelli, Serena Palmieri
    Minerva Endocrinologica.2018;[Epub]     CrossRef
  • Adrenal Imaging
    Mishal Mendiratta-Lala, Anca Avram, Adina F. Turcu, N. Reed Dunnick
    Endocrinology and Metabolism Clinics of North America.2017; 46(3): 741.     CrossRef
  • Update on the risks of benign adrenocortical incidentalomas
    Guido Di Dalmazi
    Current Opinion in Endocrinology, Diabetes & Obesity.2017; 24(3): 193.     CrossRef
  • Management Scheme for Adrenal Incidentalomas: Who Gets What?
    Glenda G. Callender, Robert Udelsman
    Current Surgery Reports.2016;[Epub]     CrossRef
  • Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
    Martin Fassnacht, Wiebke Arlt, Irina Bancos, Henning Dralle, John Newell-Price, Anju Sahdev, Antoine Tabarin, Massimo Terzolo, Stylianos Tsagarakis, Olaf M Dekkers
    European Journal of Endocrinology.2016; 175(2): G1.     CrossRef
Close layer
Case Reports
Adrenal gland
Incidentally Detected Inoperable Malignant Pheochromocytoma with Hepatic Metastasis Treated by Transcatheter Arterial Chemoembolization
Joong Keun Kim, Bo Hyun Kim, Sung Min Baek, Dong Hun Shin, Won Jin Kim, Yun Kyoung Jeon, Sang Soo Kim, In Joo Kim
Endocrinol Metab. 2014;29(4):584-589.   Published online December 29, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.4.584
  • 5,807 View
  • 34 Download
  • 8 Web of Science
  • 5 Crossref
AbstractAbstract PDFPubReader   

Malignant pheochromocytoma (PCC) is a rare condition. Although the liver is the second most frequent site of metastasis in malignant PCC, no definite treatments have been established. Herein, we report a case of liver metastasis of PCC that was successfully treated by transcatheter arterial chemoembolization (TACE). A 69-year-old man was admitted to the Department of Gastroenterology for evaluation of an incidental hepatic mass in August 2013. He had undergone right adrenalectomy in May 2005 and PCC had been confirmed on the basis of histopathological findings. Liver biopsy was performed, and metastatic PCC was diagnosed. The lesion appeared inoperable because of invasion of the portal vein and metastases in the lymph nodes along the hepatoduodenal ligament. Thus, TACE was performed instead. After TACE, symptoms including dizziness and cold sweating improved, and the patient's serum catecholamine levels decreased. On the basis of this case, we believe that TACE may be a useful treatment for liver metastasis in malignant PCC.

Citations

Citations to this article as recorded by  
  • ASTAXANTHIN INHIBITS CELL PROLIFERATION, MIGRATION, INVASION AND INDUCED APOPTOSIS VIA AMPK-mTOR SIGNALING PATHWAY IN HEPATOCELLULAR CARCINOMA HEP 3B CELLS
    SHUJUN LU, YAJING ZHANG, WENLI YU
    Cellulose Chemistry and Technology.2023; 57(9-10): 1001.     CrossRef
  • Progressive metastatic pheochromocytoma induced by multiple endocrine neoplasia type 2A with a lethal outcome
    Koshiro Nishimoto, Noriaki Lukas Santo, Masato Yonamine, Kazuhiro Takekoshi, Go Kaneko, Suguru Shirotake, Hisayo Fukushima, Yoshitaka Okada, Masanori Yasuda, Akihiro Sakurai, Masafumi Oyama, Kento Kanao
    IJU Case Reports.2022; 5(6): 459.     CrossRef
  • Astaxanthin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells via Inhibition of Nf-Κb P65 and Wnt/Β-Catenin in Vitro
    Jingjing Li, Weiqi Dai, Yujing Xia, Kan Chen, Sainan Li, Tong Liu, Rong Zhang, Jianrong Wang, Wenxia Lu, Yuqing Zhou, Qin Yin, Huerxidan Abudumijiti, Rongxia Chen, Yuanyuan Zheng, Fan Wang, Jie Lu, Yingqun Zhou, Chuanyong Guo
    Marine Drugs.2015; 13(10): 6064.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
  • Clinical course and prognostic factors in patients with malignant pheochromocytoma and paraganglioma: A single institution experience
    Yun Mi Choi, Tae‐Yon Sung, Won Gu Kim, Jong Jin Lee, Jin‐Sook Ryu, Tae Yong Kim, Won Bae Kim, Suck Joon Hong, Dong Eun Song, Young Kee Shong
    Journal of Surgical Oncology.2015; 112(8): 815.     CrossRef
Close layer
Adrenal gland
Pheochromocytoma with Markedly Abnormal Liver Function Tests and Severe Leukocytosis
Chai Ryoung Eun, Jae Hee Ahn, Ji A Seo, Nan Hee Kim
Endocrinol Metab. 2014;29(1):83-90.   Published online March 14, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.1.83
  • 6,857 View
  • 38 Download
  • 7 Web of Science
  • 9 Crossref
AbstractAbstract PDFPubReader   

Pheochromocytoma is a rare neuroendocrine tumor arising from the medulla of the adrenal glands, which causes an overproduction of catecholamines. The common symptoms are headache, palpitations, and sweating; however, various other clinical manifestations might also be present. Accurate diagnosis of pheochromocytoma is important because surgical treatment is usually successful, and associated clinical problems are reversible if treated early. A 49-year-old man with a history of uncontrolled hypertension and diabetes mellitus presented with chest pain, fever, and sweating. His liver function tests and white blood cell counts were markedly increased and his echocardiography results suggested stress-induced cardiomyopathy. His abdominal computed tomography showed a 5×5-cm-sized tumor in the left adrenal gland, and laboratory tests confirmed catecholamine overproduction. After surgical resection of the left adrenal gland, his liver function tests and white blood cell counts normalized, and echocardiography showed normal cardiac function. Moreover, his previous antihypertensive regimen was deescalated, and his previously uncontrolled blood glucose levels normalized without medication.

Citations

Citations to this article as recorded by  
  • Interplay between endocrine disorders and liver dysfunction: Mechanisms of damage and therapeutic approaches
    Andres M Vargas-Beltran, Samantha M Armendariz-Pineda, Froylan D Martínez-Sánchez, Carolina Martinez-Perez, Aldo Torre, Jacqueline Cordova-Gallardo
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • Case Report: Elevated Aminotransferases and Altered Hepatic Perfusion due to Retroperitoneal Paraganglioma
    Gabriel de Magalhães Freitas, Caroline Tomas Heringer, Ébony Lima dos Santos, Carolina Oliveira de Souza, Silvia Regina Pereira Soares, Raul Carlos Wahle
    GE - Portuguese Journal of Gastroenterology.2025; : 1.     CrossRef
  • Pheochromocytoma-Induced Leukocytosis With Concurrent Severe Eosinophilia: A Case Report
    Nouf Alnaqeeb, Mohamed M Abd Elhamid, Ihab AImagdub, Randa Ali
    Cureus.2025;[Epub]     CrossRef
  • Liver Transplantation for Fulminant Hepatic Failure Precipitated by Pheochromocytoma Crisis in the Setting of Using Garcinia cambogia Weight Loss Supplement: A Case Report
    Motaz A Selim, Krystal Weierstahl, Calvin Eriksen, Terra Pearson, Harvey Woehlck
    Cureus.2023;[Epub]     CrossRef
  • Pheochromocytoma presenting with severe abdominal pain and abnormal liver enzymes
    Mhd Baraa Habib, Mohamed Abdelrazek, Sali Alatasi, Mouhand F. H. Mohamed, Hamda Ali, Mohamad Khair Hamad
    Clinical Case Reports.2021;[Epub]     CrossRef
  • A cardiogenic shock in PICU turned out to be a bilateral pheochromocytoma: A case report
    Jay Shah, Zinkal Patel, Shradha Patel, Amit Kumar
    Journal of Pediatric Critical Care.2021; 8(5): 255.     CrossRef
  • Endocrine Diseases and the Liver
    Miguel Malespin, Ammar Nassri
    Clinics in Liver Disease.2019; 23(2): 233.     CrossRef
  • Pheochromocytoma crisis presenting with hypotension, hemoptysis, and abnormal liver function
    Renhua Wu, Nanwei Tong, Xinlei Chen, Shishi Xu, Fang Zhang, Lizhi Tang, Yuwei Zhang
    Medicine.2018; 97(25): e11054.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
Close layer
Original Article
Adrenal gland
Clinical Characteristics for 348 Patients with Adrenal Incidentaloma
Jongho Kim, Kwi Hyun Bae, Yeon Kyung Choi, Ji Yun Jeong, Keun Gyu Park, Jung Guk Kim, In Kyu Lee
Endocrinol Metab. 2013;28(1):20-25.   Published online March 25, 2013
DOI: https://doi.org/10.3803/EnM.2013.28.1.20
  • 7,588 View
  • 56 Download
  • 53 Crossref
AbstractAbstract PDFPubReader   
Background

Adrenal incidentaloma is an adrenal neoplasm frequently encountered in clinical practice for which detection rates have recently increased. We describe here the clinical characteristics of adrenal incidentalomas.

Methods

A retrospective study was performed examining the age, sex, location, size, function, and the histological findings for 348 patients with an adrenal mass discovered incidentally on computed tomography (CT) undertaken for health examination or nonadrenal disease from August 2005 to May 2012.

Results

Patients consisted of 156 males (44.8%) and 192 females (55.2%), aged between 20 and 86. Adrenal masses were most commonly found in patients in their sixth decade (32.5%). Regarding the location of the masses, 62.0% were found in the left adrenal gland, 30.2% were found in the right, and 7.8% were found bilaterally. Of all of the masses analyzed, 87.1% were 1 to 4 cm in size, and an adenoma-like appearance was the most common finding (75.3%) seen on CT scans. Hormonal analysis showed that 82.2% of the masses were nonfunctioning, 6.0% were diagnosed as subclinical Cushing's syndrome, 4.6% were aldosterone-producing adenomas, and 7.2% were pheochromocytomas. Adrenalectomy was performed in a total of 69 patients having adenoma (50.7%), pheochromocytoma (24.6%), and carcinoma (4.3%).

Conclusion

The characteristics of benign, malignant, nonfunctional, and functional adrenal masses that were incidentally found at our hospital were similar to those presented in other studies.

Citations

Citations to this article as recorded by  
  • High prevalence but low referral rate of adrenal incidentalomas in a Lebanese tertiary hospital
    Isabelle Jambart, Anne-Marie Wakim, Nadine Cheaib, Christelle Lahoud, Maryam Mansour, Carla Bou Issa, Charbel Daoud, Lina Menassa Moussa, Marie-Hélène Gannagé-Yared, Nada El Ghorayeb
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Machine learning-based classification of adrenal tumors using clinical, hormonal, and body composition data
    Seung Shin Park, Jongsung Noh, Jinhee Kim, Taesung Kim, Hae Jin Seo, Chang Ho Ahn, Jaegul Choo, Man Ho Choi, Jung Hee Kim
    European Journal of Endocrinology.2025; 193(2): 204.     CrossRef
  • The Effect of Radiological Imaging Reports in Clinical Decision-Making in the Management of Adrenal Incidentaloma
    Puren Gökbulut, Cagatay Emir Onder, Serife Mehlika Kuskonmaz
    Experimental and Clinical Endocrinology & Diabetes.2025; 133(09): 453.     CrossRef
  • Impact of Size Thresholds on the Diagnosis of Incidental Adrenal Lesions: A Systematic Review and Meta-Analysis
    Mitchell P. Wilson, Shubreet Randhawa, Bo Bao, Roger Croutze, Mohammad H. Murad, Matthew D.F. McInnes, Gavin Low
    Journal of the American College of Radiology.2024; 21(1): 107.     CrossRef
  • Adrenal incidentalomas: A seven-year follow-up single-center experience
    Danijela Radojković, Milica Pešić, Milan Radojković, Saša Radenković, Vojislav Ćirić, Ivan Ilić, Miloš Stević
    AFMN Biomedicine.2024; 41(2): 252.     CrossRef
  • Predictors of malignancy for treatment direction in patients with nonfunctioning adrenal incidentaloma
    Jongwon Jung, Byung-Chang Kim, Douk Kwon, Won Woong Kim, Yu-mi Lee, Kye Jin Park, Seung Hun Lee, Ki-Wook Chung, Tae-Yon Sung
    Surgical Oncology.2024; 56: 102122.     CrossRef
  • Demographic and Clinical Characteristics of Patients with Adrenal Incidentaloma from a Single Center in South India: A Retrospective Study
    Abhijeet B Jawanjal, Siddarth Sadananda, Nikitha Sriramaneni, Y. P. Ganavi, Pramila Kalra, Chitra Selvan, P. R. Manjunath, Praneethi K. Shetty
    Annals of African Medicine.2024; 23(4): 567.     CrossRef
  • Mature Adrenal Ganglioneuroma With Lipomatous Content: A Radiological and Histopathological Diagnostic Challenge
    Mohammed Lameir Hussein, Shams O Alkhateeb, Jouhar J Kolleri, Ala' Saleem Abu-Dayeh, Khaled Murshed, Nabil Sherif Mahmood
    Cureus.2024;[Epub]     CrossRef
  • Quantitative analysis of catecholamines and their metabolites in 491 patients with adrenal tumors: a retrospective single-center cohort study
    Hao-Long Zeng, Xu Wang, Hui-Jun Li, Qing Yang
    Journal of Cancer Research and Clinical Oncology.2023; 149(8): 4979.     CrossRef
  • Biochemical Assessment of Pheochromocytoma and Paraganglioma
    Graeme Eisenhofer, Christina Pamporaki, Jacques W M Lenders
    Endocrine Reviews.2023; 44(5): 862.     CrossRef
  • Primary Aldosteronism Prevalence – An Unfolding Story
    Suranut Charoensri, Adina F. Turcu
    Experimental and Clinical Endocrinology & Diabetes.2023; 131(07/08): 394.     CrossRef
  • Could the presence of adrenal incidentaloma negatively affect COVID 19 outcomes?
    Metin Guclu, Bilal Burcak Aslan, Tirdad Setayeshi, Sinem Kiyici
    Endocrine.2023; 82(2): 406.     CrossRef
  • Landscape of Adrenal Tumours in Patients with Congenital Adrenal Hyperplasia
    Mara Carsote, Ana-Maria Gheorghe, Claudiu Nistor, Alexandra-Ioana Trandafir, Oana-Claudia Sima, Anca-Pati Cucu, Adrian Ciuche, Eugenia Petrova, Adina Ghemigian
    Biomedicines.2023; 11(11): 3081.     CrossRef
  • CT-based Abdominal Adipose Tissue Area Changes in Patients Undergoing Adrenalectomy Due to Cushing’s Syndrome and Non-functioning Adenomas
    Elif Gündoğdu, Emre Emekli
    Experimental and Clinical Endocrinology & Diabetes.2022; 130(06): 368.     CrossRef
  • The Etiological Profile of Adrenal Incidentalomas
    Fatima-Zahra Lahmamssi, Loubna Saadaoui, Hayat Aynaou, Houda Salhi, Hanan El Ouahabi
    Cureus.2022;[Epub]     CrossRef
  • A 15-year pheochromocytoma and paraganglioma experience in a single centre: a Singapore perspective
    Yingshan Lee, Leon Yuan Rui Tan, Shaikh Abdul Kader Kamaldeen Abdul Shakoor
    Singapore Medical Journal.2022; 63(11): 649.     CrossRef
  • Clinical Characteristics and Follow-Up Results of Adrenal Incidentaloma
    Nusret Yilmaz, Esin Avsar, Gokhan Tazegul, Ramazan Sari, Hasan Altunbas, Mustafa Kemal Balci
    Experimental and Clinical Endocrinology & Diabetes.2021; 129(05): 349.     CrossRef
  • A case of adrenocortical adenoma harboring venous thrombus mimicking adrenal malignancy
    Agena Suzuki, Yuji Kamata, Tomomi Taguchi, Koji Takano, Yuto Yamazaki, Hironobu Sasano, Masayoshi Shichiri
    Endocrine Journal.2021; 68(7): 857.     CrossRef
  • Adrenal adenomas: what to do with them? Review 2
    S. Rybakov
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2021; 17(3): 241.     CrossRef
  • A Brief Overview of the Epidemiology of Pheochromocytoma and Paraganglioma in Korea
    Yun Mi Choi
    Endocrinology and Metabolism.2020; 35(1): 95.     CrossRef
  • Adrenal Incidentalomas are Tied to Increased Risk of Diabetes: Findings from a Prospective Study
    Giuseppe Reimondo, Elena Castellano, Maurizio Grosso, Roberto Priotto, Soraya Puglisi, Anna Pia, Micaela Pellegrino, Giorgio Borretta, Massimo Terzolo
    The Journal of Clinical Endocrinology & Metabolism.2020; 105(4): e973.     CrossRef
  • Adrenal İnsidentaloma ve Otonom Kortizol Sekresyonu Vakalarının İzlemi: 14 Yıllık Tek Merkez Çalışması- Retrospektif Kohort
    Nazlı Gülsoy KIRNAP, Sanem ÖZTEKİN, Neslihan Başçıl TÜTÜNCÜ
    Dicle Tıp Dergisi.2020; 47(1): 154.     CrossRef
  • Comparison between the clinical characteristics of patients with adrenal incidentalomas and those with hypertension-associated adrenal tumors in a single center in Japan
    Mari Aoe, Akira Okada, Tomoko Usui, Katsunori Manaka, Masaomi Nangaku, Noriko Makita
    Endocrine Journal.2020; 67(6): 645.     CrossRef
  • Clinical outcomes of primary aldosteronism based on lateralization index and contralateral suppression index after adrenal venous sampling in real-world practice: a retrospective cohort study
    Jeongmin Lee, Borami Kang, Jeonghoon Ha, Min-Hee Kim, Byungil Choi, Tae-Ho Hong, Moo IL Kang, Dong-Jun Lim
    BMC Endocrine Disorders.2020;[Epub]     CrossRef
  • Adrenal Incidentaloma
    Mark Sherlock, Andrew Scarsbrook, Afroze Abbas, Sheila Fraser, Padiporn Limumpornpetch, Rosemary Dineen, Paul M Stewart
    Endocrine Reviews.2020; 41(6): 775.     CrossRef
  • Presentation and outcome of patients with an adrenal mass: A retrospective observational study
    Nadeema Rafiq, Tauseef Nabi, SajadAhmad Dar, Shahnawaz Rasool
    Clinical Cancer Investigation Journal.2020; 9(5): 198.     CrossRef
  • Enfoque diagnóstico de feocromocitomas y paragangliomas
    R.M. Gómez, M. Hernaiz, V. de Miguel, L.S. Aparicio, M.J. Marín, S. Lupi, M. Barontini
    Hipertensión y Riesgo Vascular.2019; 36(1): 34.     CrossRef
  • Accuracy of new recommendations for adrenal incidentalomas in the evaluation of excessive cortisol secretion and follow‐up
    Ana Ruiz, Theodora Michalopoulou, Ana Megia, Silvia Näf, Inmaculada Simón‐Muela, Esther Solano, Laia Martínez, Joan Vendrell
    European Journal of Clinical Investigation.2019;[Epub]     CrossRef
  • Lateralizing Asymmetry of Adrenal Imaging and Adrenal Vein Sampling in Patients With Primary Aldosteronism
    Norio Wada, Yui Shibayama, Takashi Yoneda, Takuyuki Katabami, Isao Kurihara, Mika Tsuiki, Takamasa Ichijo, Yoshihiro Ogawa, Junji Kawashima, Masakatsu Sone, Takanobu Yoshimoto, Yuichi Matsuda, Megumi Fujita, Hiroki Kobayashi, Kouichi Tamura, Kohei Kamemur
    Journal of the Endocrine Society.2019; 3(7): 1393.     CrossRef
  • Incidentally detected adrenal tumors – characteristics of patients and incidence of hormonal disorders
    Iga Grochoła, Mateusz Winder, Krzysztof Kocot, Tomasz Menżyk, Jerzy Wojnar
    Annales Academiae Medicae Silesiensis.2019; 73: 74.     CrossRef
  • Characteristics of Adrenal Incidentalomas in a Large, Prospective Computed Tomography-Based Multicenter Study: The COAR Study in Korea
    Seong Hee Ahn, Jae Hyeon Kim, Seung Hee Baek, Hyeonmok Kim, Yoon Young Cho, Sunghwan Suh, Beom-Jun Kim, Seongbin Hong, Jung-Min Koh, Seung Hun Lee, Kee-Ho Song
    Yonsei Medical Journal.2018; 59(4): 501.     CrossRef
  • Severe Cushing Syndrome Due to an ACTH-Producing Pheochromocytoma: A Case Presentation and Review of the Literature
    Jenan N Gabi, Maali M Milhem, Yara E Tovar, Emhemmid S Karem, Alaa Y Gabi, Rodhan A Khthir
    Journal of the Endocrine Society.2018; 2(7): 621.     CrossRef
  • Clinical Investigation of Adrenal Incidentalomas in Japanese Patients of the Fukuoka Region with Updated Diagnostic Criteria for Sub-clinical Cushing's Syndrome
    Ichiro Abe, Kaoru Sugimoto, Tetsumasa Miyajima, Tomoko Ide, Midori Minezaki, Kaori Takeshita, Saori Takahara, Midori Nakagawa, Yuki Fujimura, Tadachika Kudo, Shigero Miyajima, Hiroshi Taira, Kenji Ohe, Tatsu Ishii, Toshihiko Yanase, Kunihisa Kobayashi
    Internal Medicine.2018; 57(17): 2467.     CrossRef
  • Mortality in Patients with Endogenous Cushing’s Syndrome
    Pedram Javanmard, Daisy Duan, Eliza B. Geer
    Endocrinology and Metabolism Clinics of North America.2018; 47(2): 313.     CrossRef
  • The Lateralizing Asymmetry of Adrenal Adenomas
    Meng Hao, Diana Lopez, Miguel Angel Luque-Fernandez, Kathryn Cote, Jessica Newfield, Molly Connors, Anand Vaidya
    Journal of the Endocrine Society.2018; 2(4): 374.     CrossRef
  • Radiology of the adrenal incidentalomas. Review of the literature
    F. A. Farrugia, G. Martikos, C. Surgeon, P. Tzanetis, E. Misiakos, N. Zavras, A. Charalampopoulos
    Endocrine Regulations.2017; 51(1): 35.     CrossRef
  • Baseline Demographic and Clinical Characteristics of Patients with Adrenal Incidentaloma from a Single Center in China: A Survey
    Lele Li, Guoqing Yang, Ling Zhao, Jingtao Dou, Weijun Gu, Zhaohui Lv, Juming Lu, Yiming Mu
    International Journal of Endocrinology.2017; 2017: 1.     CrossRef
  • Guidelines for the Management of Adrenal Incidentaloma: the Korean Endocrine Society, Committee of Clinical Practice Guidelines
    Jung-Min Lee, Mee Kyoung Kim, Seung-Hyun Ko, Jung-Min Koh, Bo-Yeon Kim, Sang-Wan Kim, Soo-Kyung Kim, Hae-Jin Kim, Ohk-Hyun Ryu, Juri Park, Jung-Soo Lim, Seong Yeon Kim, Young Kee Shong, Soon Jib Yoo
    The Korean Journal of Medicine.2017; 92(1): 4.     CrossRef
  • Case Report: An incidentaloma that catches your eye - adrenal myelolipoma
    Rosanna D'Addosio, Joselyn Rojas, Valmore Bermúdez, Flor Ledesma, Kyle Hoedebecke
    F1000Research.2017; 6: 1140.     CrossRef
  • Clinical Guidelines for the Management of Adrenal Incidentaloma
    Jung-Min Lee, Mee Kyoung Kim, Seung-Hyun Ko, Jung-Min Koh, Bo-Yeon Kim, Sang Wan Kim, Soo-Kyung Kim, Hae Jin Kim, Ohk-Hyun Ryu, Juri Park, Jung Soo Lim, Seong Yeon Kim, Young Kee Shong, Soon Jib Yoo
    Endocrinology and Metabolism.2017; 32(2): 200.     CrossRef
  • PIRMĄ KARTĄ NUSTATYTI ANTINKSČIŲ DARINIAI: 2010 IR 2014 METŲ IŠTYRIMO TAKTIKOS PALYGINIMAS
    Lina Ščerbinskaitė, Aušra Bradulskytė, Milda Girdžiūtė, Vilija Guntaitė, Žydrūnė Visockienė
    Sveikatos mokslai.2017; 27(2): 60.     CrossRef
  • Clinical significance of screening for subclinical Cushing’s disease in patients with pituitary tumors
    Daisuke Tamada, Tetsuhiro Kitamura, Michio Otsuki, Satoru Oshino, Youichi Saitoh, Iichiro Shimomura
    Endocrine Journal.2016; 63(1): 47.     CrossRef
  • Evaluación diagnóstica y terapéutica del incidentaloma suprarrenal
    Reynaldo M. Gómez, Raul Chervín, Ester M. Pardes, Susana Lupi, María Elena Surraco, Jorge Herrera, León Schurman, Claudio Gonzáles
    Revista Argentina de Endocrinología y Metabolismo.2016; 53(2): 51.     CrossRef
  • Clinical and endocrinological characteristics of adrenal incidentaloma in Osaka region, Japan
    Yukiko Tabuchi, Michio Otsuki, Soji Kasayama, Keisuke Kosugi, Kunihiko Hashimoto, Tsunehiko Yamamoto, Mamiko Tsugawa, Ikuo Mineo, Yuya Yamada, Shogo Kurebayashi, Makoto Ohashi, Yutaka Umayahara, Haruhiko Kouhara, Tadashi Nakamura, Hideki Taki, Taka-aki Ma
    Endocrine Journal.2016; 63(1): 29.     CrossRef
  • Clinicopathological Features Associated With the Prognosis of Patients With Adrenal Cortical Carcinoma
    Yun Mi Choi, Hyemi Kwon, Min Ji Jeon, Tae-Yon Sung, Suck Joon Hong, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Jae Lyun Lee, Dong Eun Song, Won Gu Kim
    Medicine.2016; 95(21): e3736.     CrossRef
  • Screening for Cushing’s syndrome: Is it worthwhile?
    Ilan Shimon
    Pituitary.2015; 18(2): 201.     CrossRef
  • Subclinical hypercortisolism in adrenal incidentaloma
    Miguel Debono, John Newell-Price
    Current Opinion in Endocrinology, Diabetes & Obesity.2015; 22(3): 185.     CrossRef
  • Incidental Adrenal Nodules and Masses: The Imaging Approach
    J. Willatt, S. Chong, J. A. Ruma, J. Kuriakose
    International Journal of Endocrinology.2015; 2015: 1.     CrossRef
  • Adrenal Incidentalomas
    Adriana G. Ioachimescu, Erick M. Remer, Amir H. Hamrahian
    Endocrinology and Metabolism Clinics of North America.2015; 44(2): 335.     CrossRef
  • Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
    Won-Young Lee
    Endocrinology and Metabolism.2014; 29(3): 251.     CrossRef
  • Clinical Characteristics and Metabolic Features of Patients with Adrenal Incidentalomas with or without Subclinical Cushing's Syndrome
    Bo-Yeon Kim, A-Reum Chun, Kyu-Jin Kim, Chan-Hee Jung, Sung Koo Kang, Ji-Oh Mok, Chul-Hee Kim
    Endocrinology and Metabolism.2014; 29(4): 457.     CrossRef
  • A rare cause of Cushing's syndrome: an ACTH-secreting phaeochromocytoma
    Lars Folkestad, Marianne Skovsager Andersen, Anne Lerberg Nielsen, Dorte Glintborg
    BMJ Case Reports.2014; 2014: bcr2014205487.     CrossRef
  • ADRENAL INCIDENTALOMAS: DIAGNOSIS AND MANAGEMENT
    E. N. Grineva, L. V. Belousova, I. V. Basek
    "Arterial’naya Gipertenziya" ("Arterial Hypertension").2013; 19(6): 532.     CrossRef
Close layer
Case Reports
A Case of Adrenal Cystic Pheochromocytoma with Contralateral Adrenocortical Adenoma Causing Subclinical Cushing's Syndrome.
Chang Jun Park, Joo Wan Seo, Hyeog Gyu Seoung, Jung Hee Koh, Yong Jae Lee, Bo Hyun Kim, In Ju Kim
Endocrinol Metab. 2012;27(4):323-328.   Published online December 20, 2012
DOI: https://doi.org/10.3803/EnM.2012.27.4.323
  • 3,012 View
  • 27 Download
  • 1 Crossref
AbstractAbstract PDF
Bilateral adrenal neoplasms are associated with metastatic cancer, pheochromocytoma and lymphoma. The coexistence of a unilateral functioning adrenocortical adenoma with contralateral pheochromocytoma is extremely rare. A 52-year-old woman complained of fatigue, headache, palpitation, and progressive weight gain. Hormonal assessment demonstrated high 24 hours urine epinephrine, norepinephrine, and free cortisol. A dexamethasone suppression test (overnight 1 mg, low dose 2 mg) showed insuppressible cortisol. Computerized tomographic scanning revealed a bilateral adrenal tumor. To preserve adrenal function, right adrenalectomy along with left adrenal tumorectomy was performed. Histological finding of the right adrenal tumor was pheochromocytoma and the left adrenal tumor was adrenocortical adenoma. This patient was the first case of a functional adrenocortical adenoma with contralateral cystic pheochromocytoma in Korea. We report the case with a review of the literature.

Citations

Citations to this article as recorded by  
  • A Case of Bilateral ACTH-independent Adrenal Adenomas with Cushing's Syndrome Treated by Ipsilateral Total and Contralateral Partial Laparoscopic Adrenalectomy
    Seung Ah Park, Dong min Jung, Soon young Kim, Nan Young Choi, Tae-jun Kim, Yong kyun Kim, Seong kyun Na, Chul Sik Kim, Seong Jin Lee, Sung-Hee Ihm, Jun Goo Kang
    The Korean Journal of Obesity.2013; 22(4): 254.     CrossRef
Close layer
A Case of Dopamine-Secreting Pheochromocytoma.
Jung Kyu Park, Hoon Kyu Oh, Moo Hyun Shon, Hyun Hee Kim, Eon Ju Jeon, Eui Dal Jung
Endocrinol Metab. 2012;27(2):159-162.   Published online June 20, 2012
DOI: https://doi.org/10.3803/EnM.2012.27.2.159
  • 67,322 View
  • 50 Download
  • 1 Crossref
AbstractAbstract PDF
A pheochromocytoma is a neuroectodermal tumor that originates from the chromaffin cells of the sympathetic system. It has typical symptoms or signs, such as periodic attacks of paroxysmal hypertension, palpitation, headache, and sweating, related to an increased catecholamine secretion. Types of catecholamine secreted from tumors are usually norepinephrine and epinerphrine. There are a few reports of dopamine-secreting pheochromocytoma with absence of other catecholamines secretion. Here, we report the case of a 59-year-old man with dopamine-secreting pheochromocytoma, with no typical symptoms or signs.

Citations

Citations to this article as recorded by  
  • Metanephrine negative pheochromocytoma: a rare case report of dopamine-secreting tumor in an adolescent neurofibromatosis type 1 patient
    Mi-Seon Lee, Rosie Lee, Sook-Hyun Park, Soon Hak Kwon, Jin-Young Park, Sang-Woo Lee, So-Mi Lee, Jung-Eun Moon
    Annals of Pediatric Endocrinology & Metabolism.2023; 28(4): 302.     CrossRef
Close layer
Original Article
Characterization of Incidentally Detected Adrenal Pheochromocytoma.
Ye An Kim, Yul Hwangbo, Min Joo Kim, Hyung Jin Choi, Je Hyun Seo, Yenna Lee, Soo Heun Kwak, Eu Jeong Ku, Tae Jung Oh, Eun Roh, Jae Hyun Bae, Jung Hee Kim, Kyoung Soo Park, Seong Yeon Kim
Endocrinol Metab. 2012;27(2):132-137.   Published online June 20, 2012
DOI: https://doi.org/10.3803/EnM.2012.27.2.132
  • 3,684 View
  • 31 Download
  • 3 Crossref
AbstractAbstract PDF
BACKGROUND
In approach to an adrenal incidentaloma, early exclusion of pheochromocytoma is clinically important, due to the risk of catecholamine crisis. The aims of this study are to investigate the characteristics of incidentally detected pheochromocytomas, compared with that of the other adrenal incidentalomas, and to compare these characteristics with those of symptomatic pheochromocytomas. METHODS: In this retrospective study, we reviewed the medical records of 198 patients with adrenal incidentaloma from 2001 to 2010. We analyzed the clinical, laboratory and radiological data of pheochromocytomas, in comparison with those of the other adrenal incidentalomas. We also compared the characteristics of these incidentally detected pheochromocytomas with the medical records of 28 pathologically proven pheochromocytomas, diagnosed based on typical symptoms. RESULTS: Among the 198 patients with adrenal incidentaloma, nineteen patients were diagnosed with pheochromocytoma. Pheochromocytomas showed larger size and higher Hounsfield unit at precontrast computed tomography (CT) than did non-pheochromocytomas. All pheochromocytomas were larger than 2.0 cm, and the Hounsfield units were 19 or higher in precontrast CT. When both criteria of size > 2.0 cm and Hounsfield unit > 19 were met, the sensitivity and specificity for the diagnosis of pheochromocytoma were 100% and 79.3%, respectively. Compared with patients with pheochromocytoma, diagnosed based on typical symptoms, patients with incidentally detected pheochromocytoma were older, presented less often with hypertension, and showed lower levels of 24-hour urine metanephrine. CONCLUSION: Adrenal incidentaloma with < 2.0 cm in size or < or = 19 Hounsfield units in precontrast CT imaging was less likely to be a pheochromocytoma. Patients with incidentally discovered pheochromocytoma showed lower catecholamine metabolites, compared with those patients with symptomatic pheochromocytoma.

Citations

Citations to this article as recorded by  
  • Guidelines for the Management of Adrenal Incidentaloma: the Korean Endocrine Society, Committee of Clinical Practice Guidelines
    Jung-Min Lee, Mee Kyoung Kim, Seung-Hyun Ko, Jung-Min Koh, Bo-Yeon Kim, Sang-Wan Kim, Soo-Kyung Kim, Hae-Jin Kim, Ohk-Hyun Ryu, Juri Park, Jung-Soo Lim, Seong Yeon Kim, Young Kee Shong, Soon Jib Yoo
    The Korean Journal of Medicine.2017; 92(1): 4.     CrossRef
  • Clinical Guidelines for the Management of Adrenal Incidentaloma
    Jung-Min Lee, Mee Kyoung Kim, Seung-Hyun Ko, Jung-Min Koh, Bo-Yeon Kim, Sang Wan Kim, Soo-Kyung Kim, Hae Jin Kim, Ohk-Hyun Ryu, Juri Park, Jung Soo Lim, Seong Yeon Kim, Young Kee Shong, Soon Jib Yoo
    Endocrinology and Metabolism.2017; 32(2): 200.     CrossRef
  • Characterization of Incidentally Detected Adrenal Pheochromocytoma
    Soon Jib Yoo, Woohyeon Kim
    Endocrinology and Metabolism.2012; 27(2): 116.     CrossRef
Close layer
Case Reports
A Case of Malignant Pheochromocytoma Presenting as Inverted Takotsubo-Like Cardiomyopathy.
Jung Eun Jang, Hyuk Hee Kwon, Min Jung Lee, Chang Hee Jung, Sung Jin Bae, Hong Kyu Kim, Woo Je Lee
Endocrinol Metab. 2012;27(1):98-104.   Published online March 1, 2012
DOI: https://doi.org/10.3803/EnM.2012.27.1.98
  • 2,559 View
  • 23 Download
AbstractAbstract PDF
Takotsubo cardiomyopathy or stress induced cardiomyopathy is characterized by acute transient left ventricular apical ballooning without significant coronary artery disease. The pathophysiology of Takotsubo cardiomyopathy remains unclear, but it has been suggested that the stress related neurohumoral factors, especially catecholamines, play an important role. Recently, several reports have described an inverted Takotsubo cardiomyopathy, which is characterized by the dysfunction of the basal and mid-ventricular segments sparing the apex of the heart. In this report, we present a case of a 50-year-old female with a transient left ventricular dysfunction in an inverted Takotsubo pattern, that later was diagnosed as a malignant pheochromocytoma.
Close layer
Laparoscopically Resected Composite Pheochromocytoma-Ganglioneuroma.
Na Rae Kim, Taeeun Kim, Jeong Nam Lee, Young Sil Eom, Dong Hae Chung, Sanghui Park, Hyun Yee Cho
Endocrinol Metab. 2011;26(4):340-344.   Published online December 1, 2011
DOI: https://doi.org/10.3803/EnM.2011.26.4.340
  • 3,227 View
  • 24 Download
  • 2 Crossref
AbstractAbstract PDF
Composite pheochromocytoma-ganglioneuroma is one of the mixed neuroendocrine-neural tumors composed of pheochromocytoma and other neural crest derivatives. To date, less than 50 cases of composite pheochromocytoma have been reported, and about 70% of the accompanying tumors were ganglioneuromas. Here, we describe six cases of composite pheochromocytoma-ganglioneuromas in five men and one woman, aged 33 to 64. The size of the tumors ranged from 3.0 to 11.0 cm, and four out of the six presented with intermittent onset of hypertension, palpitation, or dizziness. Microscopically, each tumor was composed of large pleomorphic shaped chromaffin cells arranged in the Zellballen patterns characteristic of pheochromocytoma, and they were mixed with clusters of mature ganglion cells and bundles of spindle-shaped Schwann cells characteristic of ganglioneuroma of variable proportions. All were successfully treated laparoscopically, and none were associated with multiple endocrine neoplasm syndrome or neurofibromatosis. Preoperative diagnosis of a composite pheochromocytoma-ganglioneuroma is impossible because of the low incidence rate, and the radiological findings and symptoms are similar to those of typical pheochromocytomas. Although the significance of microscopic detection of the nonpheochromocytoma component from pheochromocytoma has not yet been clarified, microscopic identification of the composite pheochromocytoma-ganglioneuroma is important because cumulative cases are used in an effort to predict the behavior of this composite tumor.

Citations

Citations to this article as recorded by  
  • A rare case of a composite phaeochromocytoma-ganglioneuroma in Australia
    Peter Pham, Benedict Kakala, Amanda Love, Archana M Sudarsan, Clement Wong
    Journal of Surgical Case Reports.2025;[Epub]     CrossRef
  • Imaging of rare medullary adrenal tumours in adults
    C.A. Maciel, Y.Z. Tang, G. Coniglio, A. Sahdev
    Clinical Radiology.2016; 71(5): 484.     CrossRef
Close layer
Case Reports and Estimated Prevalence of Adrenal Pheochromocytoma in Patients with Neurofibromatosis Type I in Korea.
Ju Yang Jung, Seun Joo Ahn, Hyung Young Yoon, Jung Min Ko, Yoon Sok Chung
Endocrinol Metab. 2011;26(3):258-262.   Published online September 1, 2011
DOI: https://doi.org/10.3803/EnM.2011.26.3.258
  • 2,624 View
  • 25 Download
AbstractAbstract PDF
We report three patients with adrenal pheochromocytoma who were associated with type I neurofibromatosis. Two of them were asymptomatic, but one case involved hypertension. We reviewed medical records and adrenal imaging, and estimated the prevalence of adrenal pheochromocytoma among neurofibromatosis type I patients in one university hospital in Korea. A total of 658 patients were coded for neurofibromatosis type I (Q85.0 with International Classification of Diseases 10 version) with clinical impression, but only 371 were confirmed via 1997 National Institute of Health criteria. Adrenal images were generated in 203 patients, and 3 of them were diagnosed with pheochromocytoma. According to the results of this study, the estimated prevalence of adrenal pheochromocytoma in type I neurofibromatosis was 0.30-1.48%.
Close layer
Mutational Analysis of the NF1 Gene in Two Families with Neurofibromatosis 1 Accompanied by Pheochromocytoma.
Hyon Seung Yi, Sei Hyun Kim, Jihoon Kim, Eun Jin Bae, Suntaek Hong, Ie Byung Park, Yu Jin Kim, Sihoon Lee
Endocrinol Metab. 2011;26(2):177-184.   Published online June 1, 2011
DOI: https://doi.org/10.3803/EnM.2011.26.2.177
  • 3,078 View
  • 25 Download
  • 2 Crossref
AbstractAbstract PDF
Neurofibromatosis type 1 (NF1) is one of the most common autosomal dominant inherited disorders affecting the nervous system. NF1 is associated with mutations in the NF1 gene, which is located on chromosome sub-band 17q11.2 and contains 57 exons spanning approximately 300 kb of genomic DNA. NF1 is caused by a loss of function mutation of the NF1 gene, a tumor suppressor gene, which encodes for neurofibromin, a GTPase-activating protein (GAP) involved in the negative regulation of Ras activity. The GAP-related domain, which is encoded for by exons 20-27a, is one of the most important functional domains in neurofibromin. The cysteine-serine-rich domain has been recognized as an important functional domain in NF1-related pheochromocytomas. As the result of many genetic analyses of NF1-related pheochromocytomas, pheochromocytoma has generally been recognized as a true component of NF1. We recently experienced two families with NF1 accompanied by pheochromocytoma. The proband of family 1 is a 31-year-old female diagnosed with NF1 and pheochromocytoma. Gene analysis of the proband and her sister showed that the mutation of the NF1 gene (c.7907+1G>A) led to the skipping of exon 53 during NF1 mRNA splicing. The proband of family 2 is a 48-year-old male who was diagnosed with the same condition. Gene analysis demonstrated the mutation of the NF1 gene (c.5206-8C>G) with missplicing of exon 37. These novel germline mutations did not fall into the GAP-related nor the cysteine-serine-rich domains, but into the C-terminal area of the NF1 gene. This suggests that the correlation between the genotype and phenotype of NF1-related pheochromocytoma is somewhat difficult to characterize. Further studies will be necessary to confirm the function of the C-terminal area of the NF1 gene and its contribution to the development of NF1 and pheochromocytoma.

Citations

Citations to this article as recorded by  
  • Mutation Spectrum of NF1 and Clinical Characteristics in 78 Korean Patients With Neurofibromatosis Type 1
    Jung Min Ko, Young Bae Sohn, Seon Yong Jeong, Hyon-Ju Kim, Ludwine M. Messiaen
    Pediatric Neurology.2013; 48(6): 447.     CrossRef
  • Oncologic manifestations of neurofibromatosis type 1 in Korea
    Eui Tae Kim, Hwan Namgung, Hyun Deok Shin, Soon Il Lee, Jee Eun Kwon, Myung Chul Chang, Dong Guk Park
    Journal of the Korean Surgical Society.2012; 82(4): 205.     CrossRef
Close layer
A Case of Pheochromocytoma Presenting as Syncope Due to Orthostatic Hypotension.
Ji Yeun Kim, Sung Woo Kim, Seung Jun Lee, Hyun Sook Kim, Eui Dal Jung, Yun Seop Kum
Endocrinol Metab. 2011;26(2):155-159.   Published online June 1, 2011
DOI: https://doi.org/10.3803/EnM.2011.26.2.155
  • 3,083 View
  • 42 Download
AbstractAbstract PDF
Patients with pheochromocytoma manifest with headache, perspiration, and palpitation. Although most patients have either sustained or paroxysmal hypertension, some patients present with hypotension. However, severe orthostatic hypotension is relatively rare in patients with pheochromocytoma. We report here on a 72-year-old woman with pheochromocytoma and she presented with recurrent syncope due to hypotension and blood pressure fluctuation. Syncope due to hypotension is unusual in patients with pheochromocytoma and only a few such cases have been reported. The present case serves to illustrate an unexpected presentation of this tumor.
Close layer
A Case of Pheochromocytoma Crisis with Acute Myocardial Infarction Induced by Glucocorticoids Administration.
Woo Sun Rou, Sang Kyung Jung, Sung Yun Lee, Yun Jeong Lee, Dong Jun Kim, Young Doo Kim, Hyung Yoon Kim, Sunhee Chang, Jung Hyun Noh
Endocrinol Metab. 2010;25(3):240-244.   Published online September 1, 2010
DOI: https://doi.org/10.3803/EnM.2010.25.3.240
  • 2,537 View
  • 29 Download
AbstractAbstract PDF
The most common symptoms of pheochromocytoma are paroxysmal or sustained hypertension, or symptoms of paroxysmal adrenergic stimulation such as palpitation, headache, and diaphoresis. These patients can on rare occasion reveal or be complicated with cardiovascular symptoms such as arrhythmia, cardiomyopathy, acute coronary syndrome and cardiogenic shock. These cardiac manifestations of pheochromocytoma may delay the diagnosis, which can cause a catastrophic outcome. A pheochromocytoma crisis is provoked by surgery, anesthesia, exercise and, several drugs and it is known to be an endocrine emergency with mortality as high as 85%. Many classes of drugs are well known to precipitate adverse reactions, but the presentation of pheochromocytoma after the administration of steroid has rarely been reported. We report here on a case of pheochromocytoma crisis with acute myocardial infarction after the patient took prednisolone. Furthermore, we discuss the mechanism of glucocorticoid induced crisis and myocardial infarction in pheochromocytoma patients.
Close layer
A Case of Pheochromocytoma Presented with Cardiogenic Shock and Followed by Spontaneous Remission.
Jae Wook Kwak, Jong Sang Kim, Yun Jong Seo, Jae Hui Jang, Sun Hui Park, Hyo Heon Kim
Endocrinol Metab. 2010;25(3):236-239.   Published online September 1, 2010
DOI: https://doi.org/10.3803/EnM.2010.25.3.236
  • 2,690 View
  • 24 Download
  • 1 Crossref
AbstractAbstract PDF
Pheochromocytoma is derived from the chromaffin cells and patients with pheochromocytoma present with several signs and symptoms by producing, storing and secreting catecholamine. Spontaneous rupture or necrosis of pheochromocytoma is extremely rare, but it can be lethal because of the dramatic change in the circulation such as an acute abdominal emergency or shock. Spontaneous remission of the clinical symptoms due to necrosis of the pheochromocytoma is rare. We describe such a case that presented with cardiogenic shock due to extensive necrosis of the pheochromocytoma and this was followed by spontaneous remission of the clinical symptoms without removal of the pheochromocytoma.

Citations

Citations to this article as recorded by  
  • Pheochromocytoma-induced cardiogenic shock successfully treated by extracorporeal circulation
    Min Young Lee, Sang Bae Lee, Hyun Seo Cha, Ji Hong You, Eui Young Choi, Jong Suk Park
    Yeungnam University Journal of Medicine.2017; 34(2): 285.     CrossRef
Close layer
A Family Presenting with Catastrophic Features due to Pheochromocytoma Associated with Multiple Endocrine Neoplasia 2A.
Yun Jung Lee, Suk Chon, Sang Ho Lee, Tae Won Lee, Chun Gyoo Ihm, Tae June Noh, Seungjoon Oh, Jeong Taek Woo, Sung Woon Kim, Jin Woo Kim, Young Seol Kim
Endocrinol Metab. 2010;25(2):135-141.   Published online June 1, 2010
DOI: https://doi.org/10.3803/EnM.2010.25.2.135
  • 2,513 View
  • 21 Download
AbstractAbstract PDF
Multiple endocrine neoplasia 2A (MEN 2A) is an autosomal dominant disease that consists of medullary thyroid carcinoma (MTC), pheochromocytoma and parathyroid hyperplasia. The activation of germ-line mutations in the RET proto-oncogene are responsible for MEN 2A. We describe here a rare case of MEN 2A in a patient who presented with an acute catecholamine-induced cardiomyopathy with cardiogenic shock and acute renal failure. The patient was diagnosed with pheochromocytoma and MTC associated with MEN 2A, which was confirmed by the detection of a RET proto-oncogene mutation at exon 11 on codon 634 (Cys634Arg). During familial screening, the patient's younger sister was found to have a benign thyroid nodule. Re-evaluation of this thyroid nodule revealed MTC with the same gene mutation. We also provide a review of the relevant literature.
Close layer
Ectopic ACTH Syndrome with Bilateral Pheochromocytoma in Multiple Endocrine Neoplasia Type 2A.
Ji Mi Moon, Yoon Jung Kim, Young Jin Seo, Hye Yoon Choi, Joo Hyong Kim, Ju Ri Park, Yun Jeong Lee, Hee Young Kim, Sin Gon Kim, Dong Seop Choi
J Korean Endocr Soc. 2009;24(4):265-271.   Published online December 1, 2009
DOI: https://doi.org/10.3803/jkes.2009.24.4.265
  • 3,380 View
  • 35 Download
  • 5 Crossref
AbstractAbstract PDF
Multiple endocrine neoplasia type 2A (MEN 2A) is an autosomal dominant syndrome characterized by the presence of medullary thyroid carcinoma, pheochromocytoma, and hyperparathyroidism. MEN 2A arises due to a germline missense mutation of the RET proto-oncogene. Specific RET mutation analysis has revolutionized the diagnosis and therapy of this disorder, and early thyroidectomy may have lowered the morbidity and mortality associated with these diseases. Ectopic adrenocorticotropic hormone (ACTH) syndrome is characterized by hypercortisolism due to the hypersecretion of ACTH outside of the pituitary gland; the most common causes are malignancies, but rarely adrenal pheochromocytoma may be the cause.

Citations

Citations to this article as recorded by  
  • Presentation of multiple endocrine neoplasia type 2A-associated ectopic cushing’s syndrome: case report and a systematic review
    Wei Wang, Wei-Ying Chen, Mei-Xian Zhang, Zhen-Yu Chen, Zhi-Lie Cao, Jun-Wei Wang, Wu-Gen Yao, Jian-Qiang Zhao, Fei-Ping Li, Hong-Yuan Yu, Jun Lu, Xiao-Ping Qi
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Pheochromocytoma With High Adrenocorticotropic Hormone Production Capacity Without Pigmentation and Cushingoid Symptoms: A Case Report With a Literature Review
    Gen Mizutani, Masashi Isshiki, Eisuke Shimizu, Daigo Saito, Akira Shimada
    Cureus.2024;[Epub]     CrossRef
  • Ectopic ACTH- and/or CRH-Producing Pheochromocytomas
    Patrick F Elliott, Thomas Berhane, Oskar Ragnarsson, Henrik Falhammar
    The Journal of Clinical Endocrinology & Metabolism.2021; 106(2): 598.     CrossRef
  • Severe Cushing Syndrome Due to an ACTH-Producing Pheochromocytoma: A Case Presentation and Review of the Literature
    Jenan N Gabi, Maali M Milhem, Yara E Tovar, Emhemmid S Karem, Alaa Y Gabi, Rodhan A Khthir
    Journal of the Endocrine Society.2018; 2(7): 621.     CrossRef
  • Adrenocorticotropic hormone (ACTH)-producing pheochromocytoma presented as Cushing syndrome and complicated by invasive aspergillosis
    Jae Ho Cho, Da Eun Jeong, Jae Young Lee, Jong Geol Jang, Jun Sung Moon, Mi Jin Kim, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
    Yeungnam University Journal of Medicine.2015; 32(2): 132.     CrossRef
Close layer
A Case of Improved Diabetes Mellitus After Removal of Nonfunctioning Adrenal Incidentaloma Diagnosed as Pheochromocytoma.
Se Kyung Park, Duk Su Kim, Mi Oh Roh, Min Soo Song, Chan Hee Jung, Jung Hwa Jung, Hyeong Kyu Park, Yeo Ju Kim, Ji Oh Mok, Sang Jin Kim, Chul Hee Kim, Dong Won Kim, Dong Won Byun, Kyo Il Suh, Myung Hi Yoo
J Korean Endocr Soc. 2009;24(3):189-194.   Published online September 1, 2009
DOI: https://doi.org/10.3803/jkes.2009.24.3.189
  • 2,371 View
  • 24 Download
AbstractAbstract PDF
Pheochromocytoma not only decreases insulin secretion but also increases insulin resistance. One third of patients with pheochromocytoma have diabetes mellitus and their clinical prognosis showed improvement after surgery. Until now, those patients whose prognosis for diabetes mellitus improved after the operation of pheochromocytoma had typical characteristics such as hypertension, palpitation, headache and elevated hormones such as Vanillylmandelic acid, metanephrine, epinephrine and norepinephrine. We present the case of a 75-year-old woman with asymptomatic adrenal incidentaloma identified as pheochromocytoma which exhibited normal biochemical test results, and after removal of the abdominal mass, her severe hyperglycemia improved.
Close layer
Graves' Disease Accompanied by Pheochromocytoma: Report of a Case.
Jin Hwa Kim, Sang Jun Lee, Ji Hye Shin, Mi Ra You, Jae Sik Jung, Sang Yong Kim, Hak Yeon Bae
J Korean Endocr Soc. 2009;24(2):126-131.   Published online June 1, 2009
DOI: https://doi.org/10.3803/jkes.2009.24.2.126
  • 2,972 View
  • 29 Download
  • 1 Crossref
AbstractAbstract PDF
We present here a rare case of Graves' disease accompanied by pheochromocytoma, and the patient showed normal urine and serum levels of catecholamines and their metabolites. A 45-year-old woman was referred to our hospital for the evaluation of a right adrenal incidentaloma that was detected by chest computed tomography. She had been diagnosed with Graves' disease 1 month previously. She had no symptoms of pheochromocytoma such as hypertension or a history of hypertension attack. Two consecutive 24-hour urine samples were sent to the lab for measurement of the catecholamines, and both samples showed normal levels of metanephrine and vanillylmandelic acid (VMA). After right adrenalectomy was performed, the final pathological diagnosis was adrenal pheochromocytoma. This case suggests that the onset of Graves' disease may be associated with excess catecholamine secreted by a pheochromocytoma. In addition, although the conventional method for detecting pheochromocytoma is to identify an increase of the urine catecholamines, physicians should be aware of the possibility of false negativity on this test.

Citations

Citations to this article as recorded by  
  • Functional retroperitoneal paraganglioma invading the inferior vena cava in the elderly, a case report and literature review
    Mohamed Aymane Loukili, Imane Assarrar, Nada El Yamani, Anass Haloui, Siham Rouf, Hanane Latrech
    International Journal of Surgery Case Reports.2023; 109: 108547.     CrossRef
Close layer
A Case of Pheochromocytoma That Presented as Inverted Takotsubo Cardiomyopathy.
Meyoung Cho, Ik Sang Shin, Ae Ryoung Jin, Jong Bin Park, Hye Jung Noh, Hun Soo Kim, Ha Young Kim, Byoung Hyun Park, Chung Gu Cho, Jin Won Jeong
J Korean Endocr Soc. 2009;24(1):47-53.   Published online March 1, 2009
DOI: https://doi.org/10.3803/jkes.2009.24.1.47
  • 2,842 View
  • 21 Download
  • 1 Crossref
AbstractAbstract PDF
A 52-year-old female was admitted to the hospital with abdominal pain. Her electrocardiogram revealed ST depressions in leads II, III, aVF and V2-5. The echocardiography showed transient cardiomyopathy with akinesia of the basal and mid portions of the left ventricle and hyperkinesia of the apex. There was no evidence of any vascular lesion on the emergency coronary angiography. She was diagnosed with pheochromocytoma by abdominal computed tomography and the post-operative pathologic examinations. These findings led us to a diagnosis of inverted Takotsubo cardiomyopathy related with pheochromocytoma. The recognition of such a rare cardiac manifestation should be considered in the diagnosis of pheochromocytoma, and especially in the circumstances of acute heart failure.

Citations

Citations to this article as recorded by  
  • A Case of Malignant Pheochromocytoma Presenting as Inverted Takotsubo-Like Cardiomyopathy
    Jung Eun Jang, Hyuk Hee Kwon, Min Jung Lee, Chang Hee Jung, Sung Jin Bae, Hong Kyu Kim, Woo Je Lee
    Endocrinology and Metabolism.2012; 27(1): 98.     CrossRef
Close layer
A Case of Graves' Disease with Pheochromocytoma.
Hye Sook Kim, Hyung Joon Joo, Yoon Seok Choi, Eun Sun Kim, Soo Yeon Park, Yun Jeong Lee, Hee Young Kim, Ji A Seo, Sin Gon Kim, Dong Seop Choi
J Korean Endocr Soc. 2007;22(6):465-469.   Published online December 1, 2007
DOI: https://doi.org/10.3803/jkes.2007.22.6.465
  • 3,158 View
  • 28 Download
  • 1 Crossref
AbstractAbstract PDF
Graves' disease is an autoimmune disorder in which thyrotropin-stimulating hormone receptor antibodies stimulate the thyroid gland. Stress hormones such as catecholamine are known to play important roles in the pathogenesis of Graves' disease. Pheochromocytoma with Graves' disease is extremely rare, and no case has been reported within the Republic of Korea. However, according to previous studies conducted abroad, pheochromocytoma influences the pathogenesis of Graves' disease by producing excessive cathecholamine. In the present report, we describe a 65-year-old female patient with paroxysmal hypertension and rapidly progressive body weight loss who was diagnosed as having Graves'disease with pheochromocytoma.

Citations

Citations to this article as recorded by  
  • Graves' Disease Accompanied by Pheochromocytoma: Report of a Case
    Jin-Hwa Kim, Sang-Jun Lee, Ji-Hye Shin, Mi-Ra You, Jae-Sik Jung, Sang-Yong Kim, Hak-Yeon Bae
    Journal of Korean Endocrine Society.2009; 24(2): 126.     CrossRef
Close layer
A Case of Spontaneous Rupture of Adrenal Pheochromocytoma.
Eun Joo Kim, Mie Jin Lim, Byoung Wook Bang, Hyun Joo Park, Seong Bin Hong, Moon Suk Nam, Yong Seong Kim, Suk Jin Choi
J Korean Endocr Soc. 2006;21(5):424-427.   Published online October 1, 2006
DOI: https://doi.org/10.3803/jkes.2006.21.5.424
  • 3,094 View
  • 31 Download
  • 3 Crossref
AbstractAbstract PDF
Although the spontaneous rupture of a pheochromocytoma is rare, it can be fatal if not promptly diagnosed. Hemorrhagic necrosis of the tumor will require an emergency operation, as this causes intraperitoneal hemorrhaging. Excessive vasoconstriction, tachycardia and labile blood pressure are the signs of a ruptured pheochromocytoma. The standard diagnostic tool of such a condition is an abdominal computed tomographic scan. Although the exact mechanism of the rupture is still unknown, a hemorrhage inside the tumor or a high intra-cortical pressure, due to rapid growth of the tumor, is known to play a major role in the pathogenesis. Herein is reported the case of a 53-year old male patient with a pheochromocytoma and an acute abdomen. The CT scan showed a left adrenal gland mass, with a hemorrhage in the left perirenal space. The patient underwent an emergency adrenalectomy, with the final histopathological diagnosis being that of a pheochromocytoma. Prompt recognition and early surgical intervention can improve outcome.

Citations

Citations to this article as recorded by  
  • Pheochromocytoma manifested as a surgical emergency
    Eugenia Yiannakopoulou
    European Journal of Surgical Oncology.2025; 51(11): 110439.     CrossRef
  • Ruptured functioning adrenal tumour, atypical presentation with renal colic and hypertension
    Amr Elmoheen, Mohamed Yousry, Ahmed Elmesery, Khalid Bashir
    BMJ Case Reports.2020; 13(12): e236050.     CrossRef
  • Spontaneous ruptured pheochromocytoma: an unusual case report and literature review
    Ye Seob Jee
    Annals of Surgical Treatment and Research.2017; 93(3): 170.     CrossRef
Close layer
Urinary Bladder Pheochromocytoma with a Long Asymptomatic Period.
Soon Hong Park, Jung Eun Lee, Sung Soo Moon, Joo Young Lee, Eui Dal Jung, Jung Guk Kim, In Kyu Lee, Bo Wan Kim
J Korean Endocr Soc. 2006;21(5):402-407.   Published online October 1, 2006
DOI: https://doi.org/10.3803/jkes.2006.21.5.402
  • 2,356 View
  • 20 Download
AbstractAbstract PDF
Pheochromocytoma arises from chromaffin cells of the paraganglionic system. Urinary bladder pheochromocytoma is very rare tumor that accounts for less than 0.06% of all urinary bladder tumors and it is less than 1% of all pheochromocytoma. Urinary bladder pheochromocytoma usually arises from the sympathetic nervous system of the bladder wall. Paroxysmal headache and palpitation precipitated by micturition are common specific symptoms of this tumor. The paroxysm commonly persists or the patients relapse in a few days or months. Herein, we report a case of urinary bladder pheochromocytoma with a long asymptomatic period.
Close layer
A Case Report of von Hippel-Lindau Disease Manifested in a Monozygous Twin.
Jin Woo Kim, Sang Jo Choi, Yeon Kyeong Kim, Sang Mi Ahn, Kyoung Eun Song, Sun Hye Jung, Dae Jung Kim, Yoon Sok Chung, Kwan Woo Lee, Il Jin Kim, Hio Chung Kang, Jae Gahb Park
J Korean Endocr Soc. 2005;20(4):395-400.   Published online August 1, 2005
DOI: https://doi.org/10.3803/jkes.2005.20.4.395
  • 3,034 View
  • 26 Download
  • 2 Crossref
AbstractAbstract PDF
Von Hippel-Lindau (VHL) disease is an autosomal dominant disease, which forms hypervascular tumors in multiple organs, such as hemangioblastomas in the retina and central nervous system, renal cell carcinomas, pheochromocytomas and cysts in various organs. Recent advances in gene testing have made it possible to screen family members for VHL disease. We experienced a 28 year-old male, who was diagnosed with bilateral pheochromocytomas through a family screening test when his elder monozygous twin brother was diagnosed with a pheochromocytoma. He received no treatment until December, 2004, when he visited the Emergency room due to a headache. A hemangioma of the cerebellum was seen in the brain MR study, leading to the diagnosis of type 2A VHL disease. An abdominal CT scan revealed no lesions of the pancreas or kidney. There was no evidence of a hemangioma in the retinal scan. The subsequent gene testing showed a germline mutation in exon 3 codon 167 of the VHL gene. The mother of the patient was revealed to have the same mutation of the VHL gene, but the elder brother of the patient did not.

Citations

Citations to this article as recorded by  
  • Germline mutation of Glu70Lys is highly frequent in Korean patients with von Hippel–Lindau (VHL) disease
    Sena Hwang, Cheol Ryong Ku, Ji In Lee, Kyu Yeon Hur, Myung-Shik Lee, Chul-Ho Lee, Kyo Yeon Koo, Jin-Sung Lee, Yumie Rhee
    Journal of Human Genetics.2014; 59(9): 488.     CrossRef
  • A Case of Type 1 von Hippel-Lindau (VHL) Disease associated with VHL Germline Mutation
    Jeong Hoon Seo, Jae Hong Yang, Pyoung Lak Choi, Yu Lee Kim, Young Sik Choi, Yo Han Park, Ji Ho Ko, Hio Chung Kang, IL Jin Kim, Jae Gahb Park
    Journal of Korean Endocrine Society.2006; 21(3): 239.     CrossRef
Close layer
A Case of Pheochromocytoma Presented with Cardiogenic Shock.
Mi Young Do, Hee Man Kim, Young Guk Ko, Sung Kil Lim, Jae Hun Jung, Namsik Chung, Yeon A Kim, Shin Ae Kang, Jae Hoon Moon, Jin Hyung Lee, Sang Tae Choi
J Korean Endocr Soc. 2005;20(3):283-288.   Published online June 1, 2005
DOI: https://doi.org/10.3803/jkes.2005.20.3.283
  • 2,753 View
  • 22 Download
  • 1 Crossref
AbstractAbstract PDF
A pheochromocytoma is a catecholamine secreting tumor, which is often overlooked when cardiovascular complications, such as acute heart failure, myocardial infarction, angina pectoris, arrhythmias, and dilated cardiomyopathy, presented as the initial clinical manifestations. Failure to identify a pheochromocytoma in these situations may be fatal. We report the case of 32-year-old female, who presented with cardiogenic shock. Echocardiography revealed severe global hypokinesia of the dilated left ventricle, with the exception of the apex. Computed tomography of the aorta showed a well-enhanced left adrenal mass, 3.5cm in diameter. A 24 hour urine collection study for catecholamines and a 131I-metaiodobenzylguanidine(MIBG) scan were suggestive of the diagnosis of a single adrenal pheochromocytoma. The patient stabilized after shock management, and recovered with intensive medical treatment. Follow-up echocardiography revealed normalized cardiac function and chamber dimensions. Thereafter, the adrenal mass was successfully removed using laparaoscopic surgery, without complications

Citations

Citations to this article as recorded by  
  • A Case of Pheochromocytoma Crisis with Acute Myocardial Infarction Induced by Glucocorticoids Administration
    Woo Sun Rou, Sang Kyung Jung, Sung Yun Lee, Yun Jeong Lee, Dong Jun Kim, Young Doo Kim, Hyung Yoon Kim, Sunhee Chang, Jung Hyun Noh
    Endocrinology and Metabolism.2010; 25(3): 240.     CrossRef
Close layer
Original Article
The Efficacy of MIBG Scan as a Diagnostic and Docalization Test for Pheochromocytoma.
Cheol Ku Park, Kyeong Won Kim, Do Hee Kim, Jae Hyeon Kim, Jun Gu Kang, San Wan Kim, Young Min Cho, Do Joon Park, Chan Soo Shin, Kyong Soo Park, Bo Youn Cho, Hong Kyu Lee, Seong Yeon Kim
J Korean Endocr Soc. 2005;20(1):21-28.   Published online February 1, 2005
DOI: https://doi.org/10.3803/jkes.2005.20.1.21
  • 2,512 View
  • 22 Download
AbstractAbstract PDF
BACKGROUND
Computed tomography(CT) is currently considered as the initial imaging procedure of choice for the localization of pheochromocytomas in most of the cases. 131I-or 123I-Metaiodobenzylguanidine scintigraphy(MIBG scan) was proven to be a highly specific tool for the detection of adrenal and extra-adrenal pheochromocytomas, but was less sensitive than CT. The present study is aimed to evaluate the usefulness of a MIBG scan in diagnosis and localization of pheochromocytoma when compared to CT. METHODS: We retrospectively evaluated 27 patients who underwent a MIBG scan for a pheochromocytoma at the Seoul National University Hospital from the year 2000 and 2002. According to the pathological and clinical findings, in 16 the patients pheochromocytoma was confirmed to be positive and the rest 11 of the patients were excluded from the study. RESULTS: Pheochromocytomas was identified in 16 patients. Eleven of them were localized in adrenal gland and 5 were extra-adrenal lesions. The sensitivity to MIBG scan in adrenal lesions and extra-adrenal lesions, was 72%(8/11) and 40%(2/5) respectively. In our study, the overall sensitivity to MIBG scan was 62%(10/16), and overall specificity was 90.9%(10/11). By CT four were identified to have equivocal biochemical abnormalities, but were definite and extraadrenal tumors by MIBG scan showed abnormal uptakes in two of them. CONCLUSION: The MIBG scan was especially useful in 2 of the 27 patients but we had no experienced about the additional benefits of a MIBG scan in the other 25 cases. Our results reveal that a MIBG scan should be performed carefully for the diagnosis and localization of a pheochromocytoma, while considering cost and time of operation.
Close layer
Evaluation Studies
Diagnostic Value of 24-hours Urinary Total Metanephrine As a Screening Test of Patients with Suspected Pheochromocytoma.
Sang Wan Kim, Kyung Won Kim, Do Joon Park, Chan Soo Shin, Kyung Soo Park, Seong Yeon Kim, Bo Youn Cho, Hong Kyu Lee
J Korean Endocr Soc. 2005;20(1):12-20.   Published online February 1, 2005
DOI: https://doi.org/10.3803/jkes.2005.20.1.12
  • 2,614 View
  • 32 Download
AbstractAbstract PDF
BACKGROUND
A pheochromocytoma is a rare cause of secondary hypertension. Its diagnosis is important as the hypertension is usually curable by resection of the tumor, whereas the condition is potentially lethal if undetected. Biochemical confirmation of excessive catecholamine production is a prerequisite to a definitive diagnosis. Various studies from other countries have indicated that measuring of the urinary metanephrine, using a specific procedure, is the single most reliable screening test for all patients suspected of having a pheochromocytoma. However, the diagnostic value of urinary metanephrine has never been reported in Korea. We investigated the diagnostic value of 24-hours urinary metanephrine in patients with a suspected pheochromocytoma. METHODS: This was a retrospective evaluation study, which included 95 patients with sustained hypertension and paroxysmal symptoms, and 38 patients with asymptomatic adrenal incidentaloma at Seoul National University Hospital, between July 2000 and October 2002. We performed the 24- hour urinary total metanephrine test on all patients. The diagnosis of a pheochromocytoma was applied only when confirmed by pathological analysis of a resected specimen. The possibility of a pheochromocytoma was ruled out when all biochemical tests were normal, which were performed at least in duplicate, or there was no evidence of a mass in abdominal radiological studies or histological verification. We determined the upper reference limit for urinary metanephrine as 1.3mg/day and calculated the sensitivity and specificity of the 24-hour urinary metanephrine test. RESULTS: Seventeen patients were diagnosed with a pheochromocytoma. The total metanephrine measurement had sensitivities and specificities of 82.4 and 73.3% in all the patients, 90.9 and 66.7% in patients with hypertension and paroxysmal symptoms, and 66.7 and 90.6% in patients with adrenal incidentaloma, respectively. CONCLUSION: The urinary total metanephrine measurement had relatively lower sensitivities and specificities than in other countries(sensitivity: 83~100%, specificity: 80~98%). The sensitivity of urinary metanephrine was relatively high in patients with hypertension and paroxysmal symptoms, and the specificity was high in patients with an adrenal incidentaloma. We suggest that normetanephrine and metanephrine should be separately measured, and a reasonable upper reference limit be used. It may also be necessary to measure urinary metanephrine together with urinary catecholamine or VMA to improve the diagnostic value of the urinary metanephrine test.
Close layer
Case Report
A Case of Apical Hypertrohic Cardiomyopathy Associated with Pheochromocytoma.
Joon Ho Moon, Sung Woo Park, Sung Hee Ihm, Cheol Young Park, Ki Won Oh, Cheol Soo Choi, Seong Jin Lee, In Kyung Jung, Eun Gyung Hong, Hyeon Kyu Kim, Doo Man Kim, Jae Myung Yoo, Moon Gi Choi, Hyung Joon Yoo, So Young Ku, Soo Kee Min
J Korean Endocr Soc. 2004;19(5):522-527.   Published online October 1, 2004
  • 1,645 View
  • 18 Download
AbstractAbstract PDF
Pheochromocytomas often present with cardiovascular manifestations, such as arrhythmia, angina pectoris and acute myocardial infarction and so on. Both dilated and nonobstructive hypertrophic cardiomyopathies are also rare complications of pheochromocytomas. In hypertrophic cardiomyopathy, an apical variant form constitutes about 25% of cases in Japan, but only 1 to 2% of those in non-Japanese populations, including Korea. The cause of apical hypertrophic cardiomyopathy (AHC) remains unknown. Recently, some cases of AHC associated with pheochromocytomas have been reported, with catecholamine thought to be an important cause. AHC associated with a pheochromocytoma has never been previously reported in Korea. Herein is reported our experience of a case of apical hypertrophic cardiomyopathy associated a pheochromocytoma with a review of the literature
Close layer
Original Article
A Case of Multiple Endocrine Neoplasia 2A with Germ Line Mutation of RET Gene.
Hee Young Kim, Ji Yeon Lee, Sung Bum Kim, Kye Won Lee, Ji A Seo, Jeong Heon Oh, Sin Gon Kim, Kyung Mook Choi, Sei Hyun Baik, Dong Seop Choi, Nan Hee Kim
J Korean Endocr Soc. 2003;18(5):481-488.   Published online October 1, 2003
  • 1,615 View
  • 19 Download
AbstractAbstract PDF
Multiple endocrine neoplasia 2A (MEN 2A) is an autosomal dominantly inherited disease, composed of medullary thyroid carcinoma, pheochromocytoma and hyperparathyroidism. The activation of germ-line mutations in the RET proto-oncogene are responsible for MEN 2. The analysis of the RET mutations has replaced the measurement of the calcitonin level in the diagnosis of the MEN carrier state. Specific RET codon mutations correlate with the MEN 2 syndromic variant, the age at onset of the medullary thyroid carcinoma (MTC) and the aggressiveness of the MTC. Herein, our experience of a 47-year-old woman, who had a bilateral pheochromocytoma and MTC, and MEN 2A confirmed by the detection of an RET proto-oncogene mutation at axon 10 on codon 618, is reported. Her sister was found to have the same mutant gene. After a total thyroidectomy and bilateral adrenalectomy, the calcitonin and catecholamine levels were normalized, and the patient discharged without problems. This case is reported, with a review of the literature.
Close layer
Case Reports
A Case of Pheochromocytoma with Ganglioneuronal Differentiation Producing Vasoactive Intestinal Peptide.
Min Ah Na, Sang Soo Kim, Dong Uk Kim, Jae Hoon Choi, Tae Kun Lee, Ok Nyu Kong, Jun Hyeop An, Jee Yeon Kim, Han Dong Sung, Chul Ho Joung, Seok Man Son, In Joo Kim, Yong Ki Kim
J Korean Endocr Soc. 2003;18(2):227-231.   Published online April 1, 2003
  • 1,618 View
  • 16 Download
AbstractAbstract PDF
Vasoactive intestinal peptide(VIP) is a 28-amino acid peptide, which may cause secretory diarrhea by stimulating the production of adenylate cyclase. Neuroendocrine tumors, secreting vasoactive intestinal peptide (VIP), are almost always of a pancreatic in origin. However, a pheochromocytoma may produce several neuropeptides, containing VIP, as they are considered to be neuroendocrine tumors. A 57-year-old woman, who presented with chronic watery diarrhea, hypokalemia, weight loss and a left adrenal mass, is described. Histologically, the tumor was diagnosed as a pheoch-romocytoma, with ganglioneuronal differentiation, and was histochemically confirmed to produce a vasoactive intestinal polypeptide. A left adrenal VIP-producing pheochromocytoma was successfully resected. After surgery, her diarrhea subsided and the electrolytes, affected neuroendocrine hormone levels, blood pressure and blood sugar level were normalized.
Close layer
A Case of Multiple Endocrine Neoplasia Type 2B associated with a M918T Mutation in RET Proto-Oncogene.
Tae Yong Kim, Jae Kyung Hwang, Min Kyong Moon, Young Joo Park, Do Joon Park, Seong Yeon Kim, Hong Kyu Lee, Yo Kyu Yoon, Bo Youn Cho
J Korean Endocr Soc. 2003;18(1):85-93.   Published online February 1, 2003
  • 1,695 View
  • 18 Download
AbstractAbstract PDF
A multiple endocrine neoplasia type 2B(MEN2B) is the most distinct and aggressive form of the MEN type 2 variants. We report a case of a 24-years-old woman with MEN2B. The patient had previously undergone a Duhamel's operation due to a megacolon at 6 years old, minor surgery to remove small tumors on the lip at 8 years old, and a bilateral osteotomy of the femur, due to coxa valga, at 15 years old. She underwent a total thyroidectomy and neck dissection, due to a growing thyroid nodule, despite thyroxine treatment, at 19 years old. The pathology revealed a medullary thyroid carcinoma. There was no history of MEN 2B in her family. She had prominent lips, multiple oral mucosal masses, and marfanoid habitus. During the subsequent follow-up, a positron emission tomogram was taken due to a persistently high level of serum calcitonin, despite repeated neck dissections, which revealed a mass in the right adrenal gland. Adrenomedullary function tests showed high levels of urinary catecholamine metabolites, and a genetic analysis of the peripheral leukocyte showed a codon 918 mutation (Met918Thr) at exon 16 of the RET proto-oncogene. The patient underwent a right adrenalectomy and the pathology revealed a pheoch-romocytoma.
Close layer
Original Article
Clinical Study of the Pheochromocytoma.
Dong Hyun Shin, Sin Gon Kim, Dong Rim Kim, Nan Hee Kim, Kyung Mook Choi, Saih Yun Baik, Dong Seop Choi, Sung Ock Suh
J Korean Endocr Soc. 2002;17(4):554-563.   Published online August 1, 2002
  • 1,599 View
  • 19 Download
AbstractAbstract PDF
BACKGROUND
Pheochromocytoma may arise within the adrenal medulla, or in other locations where sympathetic ganglia or chromaffin tissues are known to exist. Approximately 0.1% of hypertensive patients have pheochromocytoma. Most of this hypertension can be cured by surgical removal of the tumor, but lethal complication can develop if proper treatment is not prepared. Therefore, accurate diagnosis and preoperative preparation is very important. The objective of this study was to evaluate the clinical characteristics of pheochromocytoma and the blood pressure change following tumor removal. METHOD: The medical records of 45 patients [29 cases of intra-adrenal, 16 cases of extra-adrenal (paraganglioma)] diagnosed with of pheochromocytoma at Korea University Medical Center between 1991 and 2001 were reviewed. RESULTS: Twenty of the cases were male and 25 were female. The mean age of these patients was 43 years old. Hypertension, headaches, palpitations and impaired glucose tolerance were observed more frequently in cases of intra-adrenal tumor than in those of extra-adrenal. In the extra-adrenal group, abdominal pain, hypertension and nausea were more frequently observed. A biochemical study showed that the sensitivity of the test for catecholamines and metabolites in 24 hours urine was over 80%. For the localization of tumors we used abdominal CT and MIBG. The sensitivities of the CT and MIBG for the tumor localization were 97 and 91%, respectively. Blood pressures during the operations were effectively controlled by preoperative treatment with phenoxybenzamine (non-competitive, non-selective -adrenoreceptor antagonists). CONCLUSION: Surgical treatment cured 23 of the 30 cases of hypertension with pheochromocytoma. We have to take careful approaches in the care of the patient who may have pheochromocytoma, due to the various clinical signs and symptoms.
Close layer
Case Reports
A Case of Cured Diabetes Mellitus after Pheochromocytoma Removal.
Chang Kyun Hong, Yu Bae Ahn, Sul Hye Kim, Young Sik Woo, Seoung Goo Lee, Seung Hyun Ko, Ho Ki Song, Kun Ho Yoon, Moo Il Kang, Bong Yeon Cha, Kwang Woo Lee, Ho Young Son, Sung Koo Kang
J Korean Endocr Soc. 2001;16(4-5):502-507.   Published online October 1, 2001
  • 1,646 View
  • 17 Download
AbstractAbstract PDF
Pheochromocytoma is usually associated with a combination of various clinical manifestations caused by the overproduction of catecholamines. It is frequently accompanied by impaired glucose tolerance operating through 2-and-adrenergic mechanisms. A 41-year-old-woman was admitted to the hospital because of poorly-controlled diabetes mellitus and hypertension. She had suffered intermittent paroxysmal attacks of headache and chest discomfort and had been treated intermittently over a 2 year period for diabetes mellitus and hypertension. At admission, the levels of serum epinephrine, norepinephrine urinary excretion of total metanephrine, and VMA were all abnormally elevated. Adrenal CT showed a well-defined, homogenous mass in the right adrenal region and the tumor was diagnosed as pheochromocytoma. After tumor resection, the increased blood level of catecholamines, the urinary excretion of total metanephrine, and VMA were normalized, as was the hyperglycemia state. Diabetes mellitus of the patient was considered permanently resolved after tumor removal by the result of glucose tolerance in 75g oral glucose tolerance test.
Close layer
A Case of Pheochromocytoma with Acute Myocardial Infarction.
Yoo Bae Ahn, Moo Il Kang, Kwang Woo Lee, Ho Young Son, Sung Koo Kang, Bong Yeon Cha, Baek Jong Seo, Ki Yook Jang, In Jae Yoon, Sang Jun Lee, Sun Sook Park, Yong Seok Oh
J Korean Endocr Soc. 1997;12(4):655-660.   Published online January 1, 2001
  • 1,570 View
  • 18 Download
AbstractAbstract PDF
Pheochromocytoma, the catecholamine-producing tumor of chromaffin tissue, is associated with a curable form of hypertension. Recently we report the case of a 59 year-old male admitted for an acute myocardial infarction and who subsequently developed late recurrent severe ventricular arrhythmia coincident with transient hypertensive episodes. A pheochromocytoma was diagnosed on the basis of the urinary concentration of catecholamines and computerized tomography of the adrenal glands. After stabilization of his cardiac rhythm and blood pressure with alpha adrenergic blockade, the left adrenal gland, which contained the tumor, was subsequently resected. The diagnosis of a pheochromocytoma should be considered when recurrent ventricular arrhythmia are associated with intermittent hypertension after acute myocardial infarction.
Close layer
A Case of Neurofibromatosis with Bilateral Pheochromocytoma.
Hong Seung Kim, Young Gu Shin, Il Hoi Kim, Yun Mee Kim, Mee Yeon Cho
J Korean Endocr Soc. 1997;12(3):478-484.   Published online January 1, 2001
  • 1,642 View
  • 17 Download
AbstractAbstract PDF
Pheochromocytoma is originated from chromaffin cell of sympathetic nervous system and associated with other disease, such as neurofibromatosis, duodenal carcinoid, medullary thyroid cancer and parathyroid adenoma. Especially, pheochromocytoma is developed more than 50% in neurofibromatosis associated with hypertension. In such cases, several clinical features documented as more frequent bilateral phochromocytoma, more associated with other neuroendocrine tumors and thus more poor prognosis. We can observe the sustained hypertension despite of surgical resection of tumors in pheochromocytoma cases. One of the possible reason of post operative sustained hypertension is the pheochromocytoma originated from minor organ of Zukerkandl that was not resected during operation. Untreated or delayed treated cases with pheochromocytoma were often expired by complication of hypertension such as cerebrovascular hemorrhage, myocardial infarction, etc. Thus, in neurofibromatosis with hypertension, screening of pheochromocytorna is very important for the early detection of tumor and more favorable prognosis. Recently, We experienced a case of neurofibromatosis associated with bilateral pheochromocy-toma expired by cerebral hemorrhage during operation, so we report the case with literature review.
Close layer
A Case of Insulinoma Combined with Pheochromocytoma.
Si Hoon Lee, Young Hoon Youn, Sung Kil Lim, Bong Soo Cha, Hyun Chul Lee, Tae Woong Noh, Kap Bum Huh
J Korean Endocr Soc. 2000;15(4-5):640-647.   Published online January 1, 2001
  • 1,755 View
  • 35 Download
AbstractAbstract PDF
Multiple endocrine neoplasia (MEN) is a combination of endocrine tumor associations and consists of 3 types: 1, 2A and 2B. Herein, we report a case of insulinoma which is combined with pheochromocytoma discovered at the left adrenal gland which was treated by surgical resection. We think there is a possibility of a new type of multiple endocrine neoplasia (MEN).
Close layer
A Case of Pheochromocytoma Manifested by Generalized Seizure.
Young Mee Ahn, Young Ah Choi, Kyoung Won Park, Chung Hyun Chun, Chang Bai Lee, Eun Sun Hong, Yeon Ah Sung, Nan Ho Kyung
J Korean Endocr Soc. 2000;15(4-5):622-626.   Published online January 1, 2001
  • 1,284 View
  • 18 Download
AbstractAbstract PDF
Pheochromocytoma is originated from chromaffin cells of sympathetic nervous system and clinical symptoms are caused by catecholamine released from tumor. In typical cases, periodic attacks of hypertension, palpitation, headache, and sweating are main symptoms. But, the diagnosis of pheochromocytoma is sometimes difficult since its clinical presentation is quite variable. We evaluated a 25-year-old woman who was admitted because of left flank pain and seizure. She had a history of hemoptysis and toxemia. During the hospitalization, she experienced generalized seizure once more. The clinical diagnosis of pheochromocytoma was proven by highly elevated urinary catecholamines and confirmed histologically after operation. We think it is the first case report of pheochromocytoma manifested by seizure in korea, so we report this case with literature review.
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP